SlideShare a Scribd company logo
April
Issue 04
2024
Trends, Challenges
and Opportuni es
The Future of
Corporate Healthcare
Champions
of Health:
Spotlight on Leaders
Shaping
Germany's
Healthcare
Dr.
Cornelius
Glismann
Leading Tech-Driven Transforma on
in Corporate Health Preven on
Dr. Cornelius Glismann
CEO
CorporateHealth
Transforma onal and
Emo onal Competence
Healthcare Leadership
in the Digital Age
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Editor’s
Note
ermany has long been admired for
Gits high-quality and universal
healthcare system, consistently
ranking among the best in the world. It stands
as a global leader in medical innovation and
healthcare delivery. At the forefront of this
excellence are the brilliant minds and
dedicated professionals who tirelessly strive
to enhance patient care and innovate novel
treatments and technologies.
However, the nation’s healthcare system is
not stagnant – it is continuously evolving
thanks to the innovative leaders working
tirelessly to improve patient outcomes, drive
efficiencies, and embrace the latest
advancements in medical science and
technology.
In this exclusive issue, ‘Champions of
Health: Spotlight on Leaders Shaping
Germany’s Healthcare,’ we feature some of
the country’s most influential healthcare
visionaries across various sectors. From
forward-thinking physicians and researchers
to health tech entrepreneurs and
policymakers, these inspiring individuals are
leading profound changes that are modernizing
healthcare delivery, accelerating medical
breakthroughs, and improving the health and
well-being of people across Germany.
As the global population continues aging and
the prevalence of chronic diseases rises, the
need for accessible, affordable, and effective
healthcare has never been greater. The
champions featured in this edition are rising to
meet these daunting challenges head-on
through pioneering research, groundbreaking
treatments, digital health solutions, and
progressive policies and regulations.
Their stories showcase the depth of expertise,
passion for improving lives, and spirit of
innovation that is driving Germany’s
healthcare industry forward. We hope this
window into their impactful work inspires
others to join them in creating a healthier
future for all.
Immerse yourself into an enlightening read
ahead!
Sculpting a Healthier
Future f
or Germany
-Natalie May
NatalieMay
08
Dr. Cornelius Glismann
Leading Tech-Driven Transformation in
Corporate Health Prevention
Cover Story
Profiles
20 Daniel Vitt
Pioneering Biotech
Leadership
30 Wolfgang Ries
Driving Change in Spinal
Care Through Innovation
and Expertise
26
36
Articles
Healthcare Leadership
in the Digital Age
Trends, Challenges
and Opportunities
The Future of Corporate
Healthcare
Transformational and
Emotional Competence
Copyright © 2024 Insights Success Media and Technology Pvt. Ltd., All rights reserved. The content and images used in this magazine should not be reproduced or transmitted in any form or
by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission from Insights success.
Reprint rights remain solely with Insights Success Media and Technology Pvt. Ltd. Euro Health Leaders is powered by Insights Success Media and Technology Pvt. Ltd.
sales@eurohealthleaders.com
Contact Us:
Insights Success Media Tech LLC
555 Metro Place North, Suite 100,
Dublin, OH 43017, United States
Phone - +1614-602-4132
Email: info@eurohealthleaders.com
For Subscription: www.eurohealthleaders.com
Insights Success Media and Technology Pvt. Ltd.
Survey No.133/134, Brand Square, Office No. 512,
Kunjir Chowk, Pimple Saudagar, Pune,
Maharashtra 411027.
Phone - India: 7410033802, 8956487823
Email: info@eurohealthleaders.com
For Subscription: www.eurohealthleaders.com
We are also available on :
Editor-in-Chief
Thanh Truong
Managing Editor
Pearl Shaw
Executive Editor
Natalie May
Visualiser
David King
Art & Design Head
Samuel Martinez
Co-designer
Paul Belin
Art & Picture Editor
Grace Brown
Business Development
Manager
Emily Jones
Marketing Manager
Bill Thompson
Business Development
Executives
Anna Smith, Jack Miller
Sales Executives
Mike, Carl, Lisa
Technical Head
Jacob Smile
Assistant Technical Head
Joseph Taylor
Technical Consultants
David, Robert
Digital Marketing
Manager
Alina Sege
Assistant Digital
Marketing Manager
Daniel Jones
SME-SMO Executive
Gemson
Research Analyst
Eric Smith
Circulation Manager
James Carter
L E A D E R S
EUR Health
APRIL, 2024
Follow us on : www.facebook.com/eurohealthleaders/ https://twitter.com/eurohealthleaders
Brief
Featuring
Person
Company
Dr. Cornelius Glismann is a visionary leader driving
the transformation of corporate healthcare through
the integration of advanced technologies and
personalized solutions.
Daniel Vitt is committed to innovative therapies for
chronic conditions and is shaping the future of
healthcare.
Boris Pasche is a distinguished leader with over 30
years of experience in cancer medicine and research.
CorporateHealth
corporatehealth-ag.com
Dr. Cornelius Glismann
CEO
Boris Pasche
Co-founder
Daniel Vitt
CEO & President
TheraBionic
therabionic.de
Immunic Therapeutics
imux.com
Tino Galgon, an experienced professional, brings
strategic vision and leadership to the forefront,
driving innovation and excellence in the industry.
Wolfgang Ries's expertise drives innovation in
minimally invasive spinal surgery, elevating patient
care to new heights.
Lyocontract
lyocontract.de
Tino Galgon
Managing Director
Wolfgang Ries
CEO & Founder
Joimax
joimax.com
CHAMPIONS OF HEALTH: SPOTLIGHT ON
LEADERS SHAPING GERMANY'S HEALTHCARE
Dr.
Cornelius
Glismann
Leading Tech-Driven Transforma on
in Corporate Health Preven on
I always had a high
affinity for the IT sec on and
got more involved in the
development of the latest
technology for preventa ve
medical diagnos cs.
Dr. Cornelius Glismann
CEO
CorporateHealth
Cov
Story
The landscape of healthcare and preventative
medicine is undergoing a profound transformation,
with the integration of advanced technologies
reshaping the way we approach medical care. As the worlds
of health and technology converge, the need for adept
leaders who can navigate this dynamic intersection
becomes imperative. This exclusive feature spotlights one
such figure – Dr. Cornelius Glismann, the CEO of
CorporateHealth.
With over two decades of experience in national and
international healthcare business development, Dr.
Glismann has engraved a lasting mark in the industry. His
journey is marked by senior positions and influential
consultations with leading global entities such as CIGNA,
Fresenius/VAMED, Asklepios, Deloitte, and Beckman
Coulter. Armed with an M.Sc. in Industrial Engineering
from the Technical University of Aachen, Germany, and a
Ph.D. in Biomedical Engineering from the University of
Miami, USA, he possesses the necessary blend of technical
expertise and strategic vision.
In our era health prevention is increasingly becoming
synonymous with personalized solutions, and Dr.
Glismann's vision is right on point. His commitment to a
'segment of one' approach, even within large corporate
environments like Porsche, Henkel, or Nestlé, sets
CorporateHealth apart in the german industry of corporate
health prevention and medical diagnostics for employees.
Recently, CorporateHealth initiated the implementation of
state-of-the-art AI-driven solutions that bear the potential to
redefine diverse diagnostic processes. Dr. Glismann
emphasized the power of these technologies, explaining
how a simple scan of an individual's face can yield a
comprehensive health status within a mere 30 seconds. This
breakthrough not only expedites the diagnostic process in
the future but also provides individuals with personalized
health insights, avoiding traditional lengthy doctor visits.
Our editorial team had the privilege of interacting with Dr.
Glismann, unveiling the strategic decisions and innovative
approaches.
Venturing in Healthcare, Preventative Medicine and
Technology
Dr. Glismann started his career in the United States by
securing a scholarship for biomedical engineering at the
University of Miami. His early contributions included
establishing the National Healthcare Test Center for Heart
Failures, a project for the FDA that laid the foundation for
his expertise in health diagnostics and the complex
relationship between healthcare and technology.
Following his academic pursuits, Dr. Glismann dived into
the professional field with Beckman Coulter, a diagnostic
company. His role in a specialized think tank focused on
developing next-generation large laboratory haematology
diagnostics for a global program deepened his insights into
diagnostics within a specific domain. Subsequently, he
returned to Europe, his home country, after spending a
significant period in the United States.
Reflecting on his experience in both countries, Dr.
Glismann noted, "I spent a large amount in the US, which
also shaped my view on healthcare because the US is much
more focused on health than on patient repair." Contrasting
the German healthcare system, known for its efficiency in
patient care during illness, he observed a broader focus on
health itself (and disease prevention) in the US.
Upon his return to Europe, Dr. Glismann joined Deloitte
Consulting, specializing in life sciences. In this capacity, he
consulted with global and mid-sized companies, offering
strategic insights into the intersection of healthcare and
technology. He revealed, "My focus was mainly on health
diagnostics but also using the latest technological
innovations. So, throughout my whole development, I
always had a high affinity for the IT section and got more
involved in the development of the latest technology for
preventative medical diagnostics."
Quest for Innovative Prevention Medicine
Dr. Glismann's journey was ignited by his experiences,
particularly in the United States. Witnessing the strides
made in preventive medicine and cutting-edge technology,
he recognized the contrast with the state of preventative
Medicine in Europe. He envisioned an efficient health
promotion program based on best-practice preventative
medical diagnostics that could extend beyond traditional
boundaries, allowing individuals to manage their health
seamlessly, even from the comfort of their homes. He
emphasized, "So it's managing your health rather than just
diagnosing it." The central aspect lies in empowering
individuals with the knowledge and technology needed to
understand and easily take actions, in an independent and
convenient manner, regarding their health in daily life.
Practical healthcare management, according to Dr.
Glismann, centers on enabling individuals to monitor
critical parameters daily.
Champions of Health: Spotlight On Leaders Shaping Germany's Healthcare
CorporateHealth
Dr. Glismann's vision is
anchored in the proac ve
promo on of health, striving to
create a paradigm shi from
trea ng diseases to preserving
and enhancing well-being.
This proactive approach allows for early intervention or
consultation, preventing the need for deeper medical
interventions; with the former mitigating health-related
deterioration in the affected person and the latter entailing
significant savings for the healthcare systems.
Establishing CorporateHealth
During his tenure at Deloitte, Dr. Glismann gained
invaluable insights into the strategic development and
modelling of various healthcare businesses and diagnostics.
Following his professional period at Deloitte, he assumed
the role of director for one of Germany's largest local
hospital chains. Under his leadership, the hospital
underwent a transformative journey, transitioning into a
private entity. This endeavour involved significant structural
changes and analytical processes, providing him with a
profound understanding of healthcare provisioning.
His next venture led him to the Fresenius Group, where he
played a pivotal role in developing and designing healthcare
centres.
Dr Glismann at the Sports, Medicine and Health Summit 2023 in Hamburg
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Notably, one of these centres focused on
prevention, sparking Dr. Glismann's interest
in scaling up preventive medicine
initiatives. He recognized a gap in
Germany's healthcare system, which
predominantly concentrated on patient
support and treatment rather than
preventive measures.
Driven by this insight, Dr. Glismann
founded his first company—a five-star
health center in Hamburg focused on
preventative medicine and health promotion
rather than patient repair. With a sprawling
1000 square meters of top-notch
diagnostics, the center housed two leading
professors from the University of Munich.
Together, they developed the center from
scratch, catering to private patients and
corporate managers.
Building on this success, Dr. Glismann
joined forces with new partners and
established CorporateHealth in 2012.
Starting with the vision to create a
prevention medicine company,
CorporateHealth has since evolved into a
corporate diagnostics entity. His strategic
approach involved rolling out a stepwise
model that has now expanded to 25
cooperating health centres across Germany.
These centres are strategically contracted
and integrated under an IT platform,
forming a virtual chain entirely dedicated to
offer health promotion programs and
medical screenings for corporations, senior
executives and employees.
Dr. Glismann envisions CorporateHealth
transforming into a comprehensive disease
prevention and medical diagnostics
company, transcending its initial role as a
corporate diagnostics and health promotion
provider for its corporate customers and
patients.
Pioneering Preventive Medicine and
Remote Diagnostics
CorporateHealth, today a frontrunner in the
field of preventive medicine for corporates,
Innova on in a box: The IntelliGI® pa ent box for
performing colon capsule endoscopy procedures
has ventured into the world of E-health technologies. Dr.
Glismann proudly highlights the transformation of an
innovative IT platform that not only manages electronic
health records but also seamlessly integrates E-Health and
AI-based solutions from top providers in the market.
With the click of a button, individuals can now schedule
appointments, access E-Health, and run AI-based solutions
from the comfort of their homes. Dr. Glismann emphasizes,
"We have initiated the process to soon be able to offer the
full width of totally remote, hybrid, or life diagnostics,
basically head to toe." This comprehensive approach allows
individuals to track various health parameters, from heart
health to stress levels, using smartphone technology, with
the results seamlessly recorded in their electronic health
records. These records can be shared with physicians for
remote diagnostics or utilized for in-person life checks.
CorporateHealth's commitment extends internationally,
with a focus on health IT and preventive diagnostics. In
2015, Dr. Glismann, in collaboration with a partner from
New York, founded CorporateHealth International.
Headquartered in Denmark, the company pioneered tele-
remote diagnostics, initially in regions in Denmark and later
expanding to the UK and the US.
He explains the revolutionary and minimally-invasive
"capsule endoscopy", which enables patients to undergo
comprehensive colon cancer screenings from the comfort of
We have ini ated
the process to soon be able to
offer the full width of totally
remote, hybrid or life
diagnos cs, basically head
to toe.
their home. In this easy and reliable procedure they can
scan their personal risk-level without the need for sedation
or hospitalization.
This technology, is especially transformative for remote
areas like islands in Scotland, providing patients with
challenging access to healthcare. Dr. Glismann emphasizes
that this specific field focuses on early diagnostics through
remote tele-diagnostics, catering to patients who benefit
from remote access to healthcare.
CorporateHealth Interna onal Headquarter in Inverness (Scotland), United Kingdom
Leadership Anchored in Trust
With his experience as a leader of various organizations, Dr.
Glismann displays a leadership philosophy built on the
bedrock of trust. According to him, trust is not just a
guiding principle; it forms the very essence of his approach
to running these organizations.
Trust becomes the cornerstone of effective leadership in a
modern work landscape where employees operate remotely,
spanning different countries and continents. Dr. Glismann
underscores the significance of trust, confidence, and
empowerment, especially as many of his team members
work from home or in diverse locations like Asia, Spain, the
UK, and the US.
He states, "I believe in having highly empowered
employees that are passionate and whom I can trust. These
employees will in return provide me with their trust because
they are passionate, intrinsically motivated and engaged in
their work." This reciprocal trust forms the cornerstone of a
corporate culture where employees feel motivated and
empowered to contribute their best. Dr. Glismann places
considerable value on the conviction and dedication of his
team members, relying on their passion and commitment to
drive initiatives forward. This collaborative and trust-based
approach not only reinforces the team's cohesion but also
empowers individuals to excel in their roles.
Fostering Connections
Dr. Glismann actively participates in various healthcare
forums, such as the Health Captain's Club, an international
gathering of healthcare leaders. Additionally, he is engaged
in national healthcare communities, maintaining close
connections to understand the dynamics within the
ecosystem at different levels.
Driven by his passion for cutting-edge technologies, Dr.
Glismann remains closely tied to developments in AI, E-
Health, and telehealth. His involvement in these networks
not only keeps him current with the latest advancements but
also shapes the next steps in the development of
CorporateHealth's vision.
Building upon a robust platform that incorporates electronic
records and appointment booking systems, CorporateHealth
takes a proactive approach. They integrate the latest
solutions from the market securely, ensuring the
incorporation of state-of-the-art diagnostic tools. Dr.
Glismann emphasizes the integration of advancements like
AI-driven applications, particularly those emerging through
smartphones.
Sustainable Health Prevention Solutions
Considering the emerging innovations and prospective
changes in the health promotion landscape in Germany, Dr.
Cornelius Glismann identifies several critical factors, with
health-IT standing out as a prominent catalyst for change.
Equally important is the element of building confidence and
trust among CorporateHealth´s stakeholders, such as
cooperation partners, clients and users, with a particular
emphasis on GDPR compliance, a factor highly esteemed in
Germany due to the country's historical context.
Dr. Glismann highlights the importance of sustainability,
emphasizing solutions that save resources by eliminating
the need for extensive travel, doctor visits, laboratories, and
blood tests. However, he notes that the effectiveness of
these solutions hinges on widespread trust and adaptation
by the population. The acceptance of these methods is
crucial for their adoption to yield positive results.
He underscores the concept of acceptance preceding
adaptation, stressing that even if a product or solution is
well-suited for an industry or country, it must gain
acceptance, especially if trust is a factor hindering adoption.
contribute to building trust among the people, ultimately
ensuring the successful integration and acceptance of
innovative solutions in preventative medicine and health
diagnostics.
Future-Forward Health
Dr. Glismann firmly believes in the transformative impact
of early detection and preventive medicine, asserting that it
makes a significant difference in people's lives. His
philosophy centers on keeping individuals healthy, ensuring
they have the Highest Level of Care (HLC), thus optimizing
the quality and value of their lifespan.
The essence of this approach lies in proactively supporting
health, emphasizing the importance of early detection to
prevent the onset and progression of diseases. Dr. Glismann
sees this as a means to enhance customers' quality of life
and a pathway to a more efficient and effective healthcare
system.
In terms of efficiency, Dr. Glismann emphasizes the cost-
effectiveness of preventive measures. Investing €1.00 in
To establish and earn trust, CorporateHealth leverages
strong partnerships with renowned medical centres from
universities, ensuring the highest quality of medical
services, whether delivered in person or through digital
platforms. Industry partnerships with trusted names like
IBM, Porsche, and Henkel further reinforce the reliability
and safety of the technology, which is certified for GDPR
compliance.
Beyond technology, CorporateHealth places emphasis on
personal connections and communication. Dr. Glismann
notes the importance of being available around the clock,
offering advice, and ensuring that a human touch is
maintained. This human-centric approach, combined with
innovative technology, aims to bridge the gap between
cutting-edge solutions and the personal nature of health
promotion services.
Dr. Glismann emphasizes the role of physicians, not just IT
experts, as leaders in driving technology at
CorporateHealth. Collaborative partnerships, credibility,
and a deep understanding of patients and the human body
Together on the front line: Dr Glismann and CorporateHealth Business Director Franziska Saller
prevention, he notes, can potentially save 10 to 100 times
the cost that might be incurred in later stages of intervention
and treatment. This economic efficiency aligns with the
broader goal of delivering value to customers/patients while
ensuring a sustainable and resource-efficient healthcare
model.
Dr. Glismann's vision is anchored in the proactive
promotion of health, striving to create a paradigm shift from
treating diseases to preserving and enhancing well-being.
By focusing on early detection and preventive measures,
CorporateHealth aims to not only contribute to the quality
of life for individuals but also to revolutionize the efficiency
and effectiveness of healthcare delivery.
Dr. Glismann's Guide to Thriving in Corporate Health
Promotion
Dr. Glismann shares valuable advice for aspiring leaders
venturing into the field of corporate health promotion and
medical services in prevention medicine. He emphasizes the
importance of being curious and open-minded, considering
the rapid evolution occurring in this sector. However, he
compares this need for curiosity with the necessity for
patience, emphasizing the conservative nature of the
healthcare industry in Germany and its slow yet steady
cycles.
Dr. Glismann underscores the long-term commitment
required in this industry, distinguishing it from more fast-
paced consumer-centric industries. He stresses that success
in medical health promotion and all related sectors comes
from understanding and embracing the enduring nature of
the field.
Highlighting these unique challenges of medical businesses,
Dr. Glismann describes it as a complex yet fascinating
system. The complexity spans from the details of the human
body to the broader societal aspects, including financing
and politics. According to him, the layers of complexity
create a captivating environment for those who are
fascinated by challenges.
He points out that the slow development in the field offers a
distinct advantage – the ability to learn from other sectors
and adapt those learnings to their own business. This
adaptability and a genuine fascination for the complexities
and challenges inherent in medical services make it the
right field for those who want to make a meaningful
difference.
In Germany, CorporateHealth has
established collaborations with leading
centres in preventive diagnostics, renowned
for their expertise in treating athletes.
These partnerships include institutions such
as the University of Heidelberg, Charity in
Berlin, and the University of Munich,
recognized for their roles in overseeing the
health of Olympic athletes. Dr. Glismann
actively engages with leaders in Scotland
and Denmark, contributing to the
continuous enhancement of program
quality.
CorporateHealth is actively involved in
comprehensive studies analyzing the
outcomes of remote diagnostics provided.
The company actively supports research
trials through various partnerships,
encompassing both private-public and
university-public collaborations. It is not
standalone but integral to a preventive
healthcare community ecosystem.
The interconnection of various healthcare
sections, departments, and companies
forms a collective effort to derive insights
that contribute to individual well-being and
corporate performance.
Dr. Glismann acknowledges the continuous
advancements in AI, health promotion and
telehealth. These innovations, he believes,
contribute to improving overall health
outcomes and addressing issues such as
mental health in the workplace.
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
The role of a leader in healthcare is to
create an environment where people feel
empowered to provide the best possible
care to patients.
- Rana Awdish
“
Daniel
VittPioneering Biotech
Leadership
Daniel Vitt
CEO and President
Immunic Therapeutics
April 2024 www.eurohealthleaders.com
20
Biotechnology is at the forefront of transformative
healthcare advancements, and pioneering it is
Daniel Vitt, Ph.D. With a background steeped in
chemistry and a passion for computational modeling, Dr.
Vitt co-founded 4SC AG, a pioneering biotech firm. His
journey continued with the establishment of Immunic
Therapeutics, where as CEO and President, he leads a
mission to develop innovative therapies for chronic
inflammatory and autoimmune conditions. Through creative
approaches and unwavering dedication to patient welfare,
Dr. Vitt is shaping the future of biotechnology, offering new
avenues of treatment and hope for those in need.
Let’s dive into the detailed interview to explore the
transformative journey of Daniel Vitt, shaping the future of
biotechnology with passion and resilience!
Daniel, can you share with our readers a bit about your
professional background and what inspired you to
pursue a career in the biotechnology industry?
Well, this started pretty unspectacular. I studied chemistry
in Siegen and Würzburg in Germany where I graduated
focusing on quantum-chemical calculations of organic
reactions. I liked these computer simulations very much –
and still do – and this drove my interest towards the
potential to use computers for simulating chemistry and
designing new molecules. Therefore, I received my Ph.D.
from the Institute of Organic Chemistry at the University of
Würzburg with my doctoral thesis focusing on the
molecular design of small molecule therapeutics.
Starting from my Ph.D. work, I wanted to translate some of
these interesting concepts on adaptive computer modeling
into a professional setup and thus, I founded 4SC AG
together with three colleagues, where we developed a
leading in silico screening technology – today, you would
call this an AI technology. 4SC became a publicly traded
biotech company and I was responsible for technology and
research in the role of the Chief Scientific Officer (CSO)
and Chief Development Officer (CDO). While there, we
successfully transitioned the company from a technology
play into an advanced therapeutic development company
with several clinical-stage product candidates in the
pipeline and brought the company public on Frankfurt
Stock Exchange in 2005.
In 2016, together with three colleagues, we took the
opportunity to buy out the immunology assets from 4SC,
who narrowed their development pipeline focusing on an
oncology pivotal study. So, we founded Immunic in
Munich. I joined Immunic in January 2017 as CEO.
Searching for access to public markets, we completed a
reverse takeover transaction with the US company Vital
Therapies, following which we became public on
NASDAQ with headquarters in New York in 2019. Since
then, I have been serving as Chief Executive Officer,
President and Director of Immunic.
In addition to my core role at Immunic, I am currently a
member of the advisory board of a venture capital fund of
Bayern Kapital GmbH. On top of this, I also co-founded
Brauhaus Germering GmbH, a local Bavarian specialty
brewery as a kind of escalated hoppy hobby.
Looking back, I think that two things inspired me most: the
use of computer simulations for design purposes and the
possibility to develop new therapeutics which may finally
end up in a pharmacy, offering patients with severe diseases
new hope.
Could you elaborate on the mission and vision of
Immunic Therapeutics? What sets it apart from other
companies in the biotechnology sector?
We founded Immunic with the mission to develop a
pipeline of next generation selective oral therapies focused
on offering patients with chronic inflammatory and
autoimmune diseases new and clinically meaningful
treatment options. We have built an advanced, diversified
pipeline of clinical development candidates, ranging from
preclinical to phase 3 development across different
therapeutic areas and indications in immunology.
OUR FOCUS IS AND HAS
ALWAYS BEEN ON THE
PATIENTS. AND PATIENTS
DESERVE TO BENEFIT FROM
SCIENTIFIC ADVANCEMENTS –
WHICH ARE NATURALLY TIED
TO COMMERCIAL SUCCESS.
Champions of Health: Spotlight On Leaders Shaping Germany's Healthcare
,,,,
,,,,
April 2024 www.eurohealthleaders.com
21
And I think we are on the right track to achieve our
mission. In particular, with our late-stage clinical program
in multiple sclerosis, our vidofludimus calcium asset, we
were already able to show clear separation from existing,
approved MS drugs with regards to safety, tolerability and
efficacy, specifically mentioning neuroprotective effects,
which no other drug has shown so far. We think
vidofludimus calcium has the potential to be a unique
treatment option targeted to the complex biology of MS,
differentiated by its combined neuroprotective, anti-
inflammatory, and antiviral effects. We hope that many
patients with this serious autoimmune disease and its
devastating consequences for their daily life will be able to
benefit from the treatment in the not too far away future.
On top of this, we have a diversified earlier stage
development pipeline, including our IMU-856 and IMU-
381 assets. IMU-856 is a pretty cool new approach to
treating gastrointestinal disorders, aiming to regenerate the
gut wall and barrier function by a new innovative targeted
mechanism. We have already demonstrated clinical proof-
of-concept for the molecule in celiac disease and are
currently evaluating its further development path, including
options in celiac disease, but also, for example, IBD or
short bowel syndrome. IMU-381 is a development
candidate with improved overall properties to specifically
address the needs of gastrointestinal diseases.
Could you discuss a key milestone or achievement
during your tenure at Immunic that you are particularly
proud of, and how it reflects your leadership style?
I am convinced that good science and entrepreneurial spirit
pave the way to success in our industry. The biggest
challenge in biotech, however, is financing drug
development. Looking back, it was a smart move to reverse
merge with Vital Therapies in 2019 to become listed on
NASDAQ – this gave us access to the capital markets and
to the US investor base. Meanwhile, we were able to
advance the development of our lead molecule
vidofludimus calcium into clinical phase 3 in relapsing
multiple sclerosis – and we also were able to demonstrate
that our drug has a very unique mode of action which could
change the life of millions of people suffering from MS.
What are the most significant challenges and
opportunities facing the biotechnology industry today,
and how is Immunic positioned to address them under
your leadership?
I think that the financing of biotech is still by far the biggest
challenge, and this needs intelligent and creative
April 2024 www.eurohealthleaders.com
22
I believe in two key success
factors: passion and
resilience. Without
passion, it is hard to reach
any goal and without
resilience, you may fail
even before you start the
journey. Resilience also
covers an important aspect
in our industry: if you are
convinced and you have
sufficient data and a strong
scientific rationale, you
should focus on the goal
and not let yourself be
frightened too much.
However, one should keep
a certain level of self-
reflection – personally and
professionally: Am I the
ghost rider – are the other
1000 coming against me?
- Daniel Vitt
Insights for
Asping aders
April 2024 23
approaches by leaders to be solved. At Immunic, we
always followed an adaptive approach and tried to build
a portfolio of development programs that allows us some
flexibility and independent efforts on financing,
including dilutive and non-dilutive financing.
The second biggest challenge from my point of view is
the changing environment, including an aging
population and political headwinds, such as the Inflation
Reduction Act (IRA). We all need to stand together and
focus on messaging to the public how important fair
pricing of new treatments for unmet medical needs is,
because this is the only way to finance breakthroughs in
the healthcare space.
How do you approach promoting innovation and
driving growth within Immunic Therapeutics,
ensuring a balance between scientific advancement
and commercial success?
Our focus is and has always been on the patients. And
patients deserve to benefit from scientific advancements
– which are naturally tied to commercial success. At
Immunic, we start with the question “How can we
improve the patient’s life?” and “What innovations can
help us to be better with our approaches?” One example
is our lead product vidofludimus calcium: offering
patients a potential neuroprotective treatment could be a
major breakthrough in the treatment landscape and
change the life of many patients around the world in a
sustainable way, while offering a treatment option that
does not come with the typical safety and tolerability concerns
of patients.
Could you share a glimpse into the future of Immunic
Therapeutics under your guidance, highlighting any
upcoming projects or initiatives that our readers should
look out for?
Our key focus at the moment and the upcoming milestone we
are most excited about is the readout of our phase 2
CALLIPER trial of vidofludimus calcium in progressive MS,
which is expected in April 2025. If this data set continues to
show a neuroprotective effect of the drug, we may be able to
position vidofludimus calcium as the first oral treatment option
for advanced Secondary Progressive MS (SPMS) – an
indication with a particularly high unmet medical need within
the MS space.
In addition, we eagerly await the readout of our two phase 3
ENSURE trials of vidofludimus calcium in relapsing MS, both
expected in 2026. Considering the promising clinical activity
observed thus far, along with vidofludimus calcium's
established safety and tolerability profile, we believe that the
ENSURE program will enable a straightforward path toward
potential regulatory approval. For every biotech company, this
is the one key milestone to achieve, and I hope that we will see
this not too far from now.
April 2024 www.eurohealthleaders.com
24
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
May 2024 www.eurohealthleaders.com
26
The Future of
Corporate
HEALTHCARE
April 2024 www.eurohealthleaders.com
27
he corporate healthcare landscape is undergoing a
Tsignificant transformation, driven by a confluence
of factors such as technological advancements,
changing workforce demographics, and evolving regulatory
environments. As businesses strive to attract and retain top
talent while managing rising healthcare costs, the way they
approach employee health and well-being is evolving
rapidly.
In this article, we explore the key trends, challenges and
opportunities shaping the future of corporate healthcare.
Trends:
1. Embracing Digital Health Solutions: The rapid
proliferation of digital health technologies, such as
telemedicine, mobile health apps, and wearable devices, is
revolutionizing the way healthcare is delivered within
corporate settings. These technologies offer convenience,
cost-effectiveness, and real-time monitoring capabilities,
enabling employees to access care more readily and
employers to better manage healthcare expenses.
2. Focus on Preventive Care and Wellness: Recognizing the
long-term benefits and cost savings associated with
preventive care, many corporations are shifting their focus
toward comprehensive wellness programs. These initiatives
aim to promote healthy lifestyles, improve employee
engagement, and reduce the risk of chronic conditions,
ultimately leading to a healthier, more productive
workforce.
Trends, Challenges and Opportuni es
3. Personalized Healthcare: With the advent of precision
medicine and advanced data analytics, corporate healthcare
is moving towards a more personalized approach. By
leveraging employee health data, employers can tailor
wellness programs, preventive screenings, and treatment
plans to meet the unique needs of their workforce, leading
to better health outcomes and cost optimization.
4. Workplace Mental Health Support: Mental health issues
have become a growing concern in the corporate world,
with stress, burnout, and anxiety taking a toll on employee
well-being and productivity. As a result, companies are
increasingly recognizing the importance of providing
comprehensive mental health support, including employee
assistance programs, counseling services, and mental health
awareness initiatives.
Challenges:
1. Rising Healthcare Costs: Despite efforts to control
expenses, healthcare costs continue to rise, straining
corporate budgets and posing a significant challenge for
employers. Balancing the need to provide comprehensive
healthcare coverage while managing costs remains a
delicate equilibrium for many organizations.
2. Data Privacy and Security Concerns: As digital health
technologies become more prevalent, concerns around data
privacy and security have emerged. Employers must
navigate complex regulations and implement robust data
protection measures to safeguard sensitive employee health
information while still leveraging the benefits of these
technologies.
3. Employee Engagement and Adoption: Implementing
effective corporate healthcare programs requires active
employee engagement and adoption. Overcoming barriers
such as lack of awareness, resistance to change, and cultural
norms can be challenging, necessitating thoughtful
communication strategies and incentives to encourage
participation.
4. Managing a Multigenerational Workforce: With multiple
generations in the workforce, corporate healthcare
programs must cater to diverse needs and preferences.
Tailoring programs to address the unique health concerns
and communication styles of different age groups can be a
complex undertaking for employers.
Opportunities:
1. Leveraging Partnerships and Collaborations:
Collaborating with healthcare providers, insurers, and
technology companies can unlock new opportunities for
corporations to enhance their healthcare offerings. By
leveraging the expertise and resources of these partners,
employers can gain access to cutting-edge solutions,
streamline processes, and provide comprehensive care to
their employees.
2. Integrating Workforce Analytics: By harnessing the
power of workforce analytics, corporations can gain
valuable insights into employee health trends, risk factors,
and the effectiveness of their healthcare programs. These
insights can inform data-driven decision-making, allowing
employers to optimize their strategies and allocate
resources more effectively.
3. Promoting Corporate Wellness Cultures: Creating a
culture of wellness within the organization can have far-
reaching benefits beyond just healthcare cost savings. A
healthy workforce is often more engaged, productive, and
resilient, contributing to overall organizational success.
Employers have the opportunity to foster a positive work
environment that prioritizes employee well-being.
4. Exploring Innovative Benefit Models: As the healthcare
landscape evolves, employers can explore innovative
benefit models that better align with their workforce needs
and organizational goals. This could include adopting
value-based healthcare models, exploring alternative care
delivery methods, or implementing consumer-driven health
plans.
Conclusion
A complex interplay of trends, challenges and opportunities
shapes the future of corporate healthcare. By staying
abreast of these developments and proactively addressing
the challenges, corporations can position themselves to
provide comprehensive, cost-effective, and innovative
healthcare solutions that support the well-being of their
employees and drive organizational success.
-Natalie May
April 2024 www.eurohealthleaders.com
28
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Wolfgang Ries
CEO & Founder
joimax®
April 2024 www.eurohealthleaders.com
30
ermany boasts a healthcare sector distinguished by
Gits excellence, marked by world-class medical
infrastructure, stringent standards, and a steadfast
dedication to patient welfare. With a robust healthcare
system emphasizing accessibility, quality, and innovation,
Germany serves as a cornerstone in shaping the future of
global healthcare.
®
Wolfgang Ries, the CEO and Founder of joimax ,
emerges as a prominent figure within this dynamic
healthcare environment. Through his entrepreneurial drive
and visionary leadership, Ries has not only navigated but
also significantly influenced the German healthcare
®
landscape. As the driving force behind joimax , he has
leveraged Germany’s healthcare expertise to propel
endoscopic minimally invasive spinal surgery to
unprecedented levels of success.
In this edition of ‘Champions of Health: Spotlight on
Leaders Shaping Germany’s Healthcare,’ we delve into
Ries’ extraordinary journey, his pioneering contributions,
and his steadfast commitment to advancing patient care.
Let’s dive into the details below!
Wolfgang, can you share with our readers a brief
overview of your professional journey that led you to
®
establish joimax ?
As a trained telecommunication technician, I graduated
from evening high school and I studied medicine later in
Vienna. That was the ideal prerequisite for combining
medicine and engineering to constantly drive new ideas.
My motivation has always been to help people, and I have
®
continuously followed this path. I started joimax in 2001 in
the basement and garage of my house together with my
®
wife Irmgard. Before founding joimax , I worked for 9
years in various positions in sales, product and marketing
management, was VP Business Development Europe at the
Baxter CardioVascular Group, now Edwards LifeScience. I
was Managing Director of the Franco-German company
Saphir Medical for 2 years and held during my 3 years as a
consultant the position of VP Marketing & Business
Development at HydroCision Inc, Andover, MA.
What inspired you to focus on endoscopic minimally
invasive spinal surgery within the healthcare industry?
The human spine is the very sensitive but also strongest
structure of the musculoskeletal system and one of its most
complex organs.
Wolfgang
RiesDriving Change in Spinal
Care Through Innovation
and Expertise
I believe in fostering a culture of
collaboration and teamwork as
well as empowerment within the
organization. By encouraging
open communication and valuing
diverse perspectives, I ensure that
decisions are well-informed and
reflective of the collective
wisdom of the team.
Champions of Health: Spotlight on Leaders Shaping Germany's Healthcare
April 2024 www.eurohealthleaders.com
31
If there are problems within this complex system specialists
are required and special technologies are needed to treat as
gentle but also powerful as possible the various diseases. In
2000 I arrived in the spine field and on one hand I was
shocked, how crude standard surgery was still done for
small diseases then, and on the other hand how well and
fast I could develop specific instruments and tools for
curing with first pioneering surgeons such widespread
diseases.
Endoscopic minimally invasive spinal surgery has the
potential to make a significant impact on patient care and
healthcare delivery. By minimizing surgical trauma,
reducing hospital stays, and speeding up recovery times,
these techniques not only benefit individual patients but
also contribute to overall healthcare efficiency and
cost-effectiveness. This potential for highly meaningful
clinical impact motivates me to focus efforts on advancing
endoscopic spinal therapy.
®
What is the core mission of joimax , and how does it
guide the company’s strategic direction under your
leadership?
®
joimax focuses on innovative technologies, systems and
methods for endoscopic minimally invasive spinal surgery.
On one hand, we guarantee the best possible and
particularly gentle treatment technologies for patients and,
on the other hand, complete systems ensure that the surgeon
can work most safely and cost-optimized on a daily basis.
®
In line with the joimax philosophy “Endoscopic Spine
Experts”, we develop professional medical applications
using endoscopy - always adapted to the increasing needs
®
of users and patients globally. joimax constantly tries to
implement the latest scientific findings and technologies. In
addition, the day-to-day practical experience of our
customers and their ongoing feedback helps us to
continuously improve our products and processes.
®
How does joimax differentiate itself in the market, and
what sets it apart in the field of endoscopic minimally
invasive spinal surgery?
®
joimax offers highly specialized complete systems for
endoscopic minimally invasive spinal surgery techniques
and is fully focused on this market segment.
April 2024 www.eurohealthleaders.com
32
Our strength lies in the development, manufacturing,
marketing and even educating and training of all application
systems, methods and devices to users around the globe. On
®
the base of over 500 patents and trademarks to date joimax
products are marketed in more than 60 countries, in Europe,
®
America, Asia, Middle East and Africa. Under ESPINEA ,
®
the in 2019 inaugurated and joimax powered “Endoscopic
Spine Academy,” more than 6,000 surgeons had been
trained on the more than 15 systems for treating spinal
diseases.
Our surgical solutions enable the gentlest possible
treatment, always with the patient’s well-being in mind. All
systems and applications are constantly monitored and
users ongoingly publish their findings and results with
®
joimax systems treated patients in international well
recognized journals. Outstanding product quality is
guaranteed by certified quality management systems in
place in accordance with international standards. In
addition, products are “Made in Germany”. Above all that,
®
joimax is constantly expanding the range of methods,
instrument sets and the associated electronic devices.
How do you approach leadership and decision-making
®
within joimax , considering your extensive experience in
healthcare and business?
My approach is always multifaceted and adaptable to the
specific needs and challenges of the organization and
industry. I believe in fostering a culture of collaboration and
teamwork as well as empowerment within the organization.
By encouraging open communication and valuing diverse
perspectives, I ensure that decisions are well-informed and
reflective of the collective wisdom of the team. This
approach not only enhances the quality of decision-making
but also promotes employee engagement and ownership.
The healthcare industry is characterized by rapid
technological advancements and changes, evolving
regulatory frameworks, and shifting patient demands and
needs. In such a dynamic environment, I prioritize
adaptability and agility in leadership and decision-making
processes. This entails being receptive to change,
proactively seeking opportunities for innovation,
anticipating market needs and swiftly adjusting course
when necessary.
What key values or principles do you believe have been
crucial to your success as the CEO and Founder of
®
joimax ?
Having a clear vision of the company’s purpose, goals, and
direction provides a roadmap for success. This vision
inspires and motivates both myself and my team to work
towards common objectives, but also users facing the
®
enthusiasm of joimax employees acting as a team driven by
patient demand. Focus on our mission and prioritization on
currently required tasks and duties had always been and will
be key drivers for our long term and lasting success.
Embracing innovation and fostering a culture of creativity
and forward thinking enables us to stay ahead of the curve in
a rapidly evolving industry. Placing the needs and interests
of our customers at the center of everything we do ensure
that our products and services are relevant, valuable, and
impactful. Building strong customer relationships and
actively soliciting feedback helps us continuously improve
and adapt to changing market demands.
Recognizing that individual success, but also global acting
®
joimax teams performance, together with our customers,
has to do with looking in every detail for being collectively a
top performer. I value very high collaboration, teamwork,
and diversity of thought within my organization.
Could you highlight a significant challenge you faced in
®
your career and how you overcame it to drive joimax ’s
growth?
®
We started to FDA register joimax products in 2005 already
®
and incorporated joimax Inc. as a Delaware corporation in
2006. Until 2011 we could start developing the endoscopic
spine surgery market in the USA, but as of January 2012 the
reimbursement all of a sudden was blocked due to a new
language in the AMA (American Medical Association) CPT
Codebook. From that time onwards only cash pay and very
special indications for endoscopic spinal procedures had
been reimbursable. On this basis one of our start-up
competitors went bankrupt and others left the US market.
Together with our investors we analyzed the situation and
finally decided that I will fight the US reimbursement system
for obtaining a specific reimbursement schematic, which
took 5 years to achieve.
As of January 2017, the new AMA CPT Codebook contained
the special language which from that time onwards allowed
reimbursement of endoscopic spinal surgery procedures.
Moreover, even a special reimbursement code was released
stimulating a clear ramp-up of business activity and adoption
of endoscopic spinal surgery in the USA. Today US surgeons
are key drivers in highly ranked publications in top journals
studying the significant cost-/outcome benefit ratios of
April 2024 www.eurohealthleaders.com
33
endoscopic spinal surgery versus traditional open surgery
methods.
What advice would you share with aspiring healthcare
professionals and entrepreneurs looking to make a
difference?
Healthcare has always been but is even more ripe for
innovation today, with endless opportunities to improve
processes, develop new treatments, and enhance patient
care. Embrace innovation and be open to exploring novel
ideas and technologies that have the potential to
revolutionize the industry.
Stay abreast of the latest developments, trends, and
challenges in healthcare. Continuously educate yourself
through reading journals, attending conferences, and
engaging in professional development activities to remain
informed and be up to speed in your field.
Always prioritize the needs and well-being of patients.
Listen to their concerns, involve them in decision-making,
and strive to deliver personalized, compassionate care that
meets their individual preferences and values.
Don’t let fear of failure hold you back from pursuing
innovative ideas or opportunities. Learn from mistakes,
take those to heart, rise up again and keep driving your
ideas to your mission where you are assured new solutions
can have its place and finally will be needed.
You will be needed within a special space of activity you
identify for yourself.
April 2024 www.eurohealthleaders.com
34
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
The healthcare industry is being reshaped by the forces of
digital transformation, introducing new technologies,
care delivery models, and patient expectations. Amidst
this whirlwind of change, healthcare organizations are struggling
with the challenge of adapting and succeeding in the digital age.
Effective leadership has emerged as a critical success factor, with
a growing emphasis on the complementary competencies of
transformational leadership and emotional intelligence.
Let us explore how these leadership styles can help attain
success in the digital age!
Transformational Leadership: Catalyzing Innovation and
Driving Change
This is a leadership approach that inspires followers to transcend
their self-interests for the greater good of the organization. In the
context of healthcare, transformational leaders play a crucial role
in championing innovation, of cultivating a culture of continuous
improvement, and effectively navigating organizational change.
At the core of transformational leadership is the ability to
articulate a compelling vision for the future. This vision should
not only encompass technological advancements but also
prioritize patient-centered care, quality improvement, and
operational efficiency. By painting a clear picture of the desired
future state, transformational leaders can rally their teams around
a shared purpose and inspire them to embrace the changes
necessary to realize that vision.
Moreover, transformational leaders must create an environment
that encourages creativity and innovation. Healthcare organiza-
tions that cultivate a culture of psychological safety, where
employees feel comfortable voicing their ideas and challenging
Healthcare
Leadership
in the Digital Age
April 2024 www.eurohealthleaders.com
36
Transforma onal and Emo onal Competence
April 2024 www.eurohealthleaders.com
37
the status quo, are better positioned to drive innovation and
stay ahead of the digital curve.
Empowering teams and encouraging their participation in
decision-making processes is another hallmark of
transformational leadership. By delegating authority and
involving team members in the change process,
transformational leaders can foster a sense of ownership
and commitment, ultimately increasing the likelihood of
successful change implementation.
Emotional Intelligence: Building Trust, Resilience, and
Collaboration
While transformational leadership focuses on driving
change and innovation, emotional intelligence is equally
crucial for healthcare leaders in the digital age. Emotional
intelligence encompasses self-awareness, self-regulation,
motivation, empathy, and social skills – all of which are
essential for building trust, fostering resilience, and
navigating the emotional complexities inherent in
healthcare settings.
Self-awareness, the cornerstone of emotional intelligence,
allows healthcare leaders to have a deep understanding of
their strengths, weaknesses, values, and emotions. This self-
knowledge enables them to make informed decisions,
manage their emotions effectively, and lead with authentic-
ity, which is essential for building trust and credibility
among their teams and stakeholders.
Empathy, another key component of emotional intelligence,
is particularly important in the healthcare context. Leaders
who can empathize with their teams, patients, and families
are better equipped to provide compassionate care and
create a supportive environment that prioritizes the well-
being of all stakeholders.
Furthermore, emotional intelligence enables healthcare
leaders to build resilience – a critical skill in the face of the
ever-changing digital landscape. By effectively managing
their emotions and maintaining a positive outlook, emotion-
ally intelligent leaders can weather the storms of change
and uncertainty, while inspiring their teams to do the same.
Collaboration and effective communication are also
facilitated by emotional intelligence. Leaders who possess
strong social skills can build and maintain productive
relationships, facilitate open dialogue, and navigate
conflicts constructively – all of which are essential for
driving organizational change and fostering a cohesive,
high-performing team.
Integrating Transformational and Emotional Compe-
tence
While transformational leadership and emotional intelli-
gence are distinct concepts, they are inextricably linked in
the context of effective healthcare leadership.
Transformational leaders who possess emotional intelli-
gence are better positioned to inspire and motivate their
teams, build trust and credibility, and navigate the complex-
ities of the digital age with grace and resilience.
Emotionally intelligent transformational leaders can
leverage their self-awareness and empathy to tailor their
communication and change management strategies to the
unique needs and concerns of their teams and stakeholders.
By actively listening and addressing concerns with empathy
and compassion, they can facilitate a smoother transition to
new digital healthcare models and technologies, while
minimizing resistance and fostering buy-in.
Moreover, emotionally intelligent transformational leaders
can role model the behaviors they seek to cultivate in their
teams. By demonstrating self-regulation, resilience, and a
growth mindset, they can inspire their teams to embrace
change, learn from setbacks, and continuously develop their
skills and capabilities – essential attributes for thriving in
the rapidly evolving digital healthcare landscape.
Conclusion
In the era of digital transformation, healthcare organizations
are facing unprecedented challenges and opportunities.
Navigating this complex field demands a unique blend of
leadership competencies that combines the visionary and
change-driving qualities of transformational leadership with
the interpersonal and emotional intelligence skills necessary
for building trust, fostering resilience, and facilitating
effective collaboration. By integrating these complementary
competencies, healthcare leaders can inspire and guide their
organizations through the digital age, delivering better
patient outcomes and a more sustainable, future-ready
healthcare system.
-Natalie May
April 2024 www.eurohealthleaders.com
38
Stay in touch.
Subscribe to Euro Health Leaders and
get the magazine in print, & digital on
www.eurohealthleaders.com
Email: info@eurohealthleaders.com
For Subscription: www.eurohealthleaders.com
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Innovation
distinguishes between a
leaderand a
follower.
L E A D E R S
EUR Health
www.eurohealthleaders.com

More Related Content

Similar to Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf

10 Most Innovative CRO’s To Watch In 2022.pdf
10 Most Innovative CRO’s To Watch In 2022.pdf10 Most Innovative CRO’s To Watch In 2022.pdf
10 Most Innovative CRO’s To Watch In 2022.pdf
insightscare
 
The 20 most disruptive healthcare solution providers 2018
The 20 most disruptive healthcare solution providers 2018The 20 most disruptive healthcare solution providers 2018
The 20 most disruptive healthcare solution providers 2018
insightscare
 
The Art of Healthcare Innovation
The Art of Healthcare InnovationThe Art of Healthcare Innovation
The Art of Healthcare Innovation
christinaeavynwarner
 
The 10 Successful Magnetic Leaders Revamping The Healthcare
The 10 Successful Magnetic Leaders Revamping The HealthcareThe 10 Successful Magnetic Leaders Revamping The Healthcare
The 10 Successful Magnetic Leaders Revamping The Healthcare
Merry D'souza
 
10 Most Innovative CROs To Watch In 2023.pdf
10 Most Innovative CROs To Watch In 2023.pdf10 Most Innovative CROs To Watch In 2023.pdf
10 Most Innovative CROs To Watch In 2023.pdf
insightscare
 
The 10 successful magnetic leaders revamping the healthcare, 2020 compressed ...
The 10 successful magnetic leaders revamping the healthcare, 2020 compressed ...The 10 successful magnetic leaders revamping the healthcare, 2020 compressed ...
The 10 successful magnetic leaders revamping the healthcare, 2020 compressed ...
Merry D'souza
 
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
insightssuccess2
 
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
insightscare
 
Top 10 pioneering leaders redefining healthcare 2021(8) compressed
Top 10 pioneering leaders redefining healthcare 2021(8) compressedTop 10 pioneering leaders redefining healthcare 2021(8) compressed
Top 10 pioneering leaders redefining healthcare 2021(8) compressed
insightssuccess2
 
Final file - Top 5 Visionary Leaders to Watch in Healthcare Industry 2023.pdf
Final file - Top 5 Visionary Leaders to Watch in Healthcare Industry 2023.pdfFinal file - Top 5 Visionary Leaders to Watch in Healthcare Industry 2023.pdf
Final file - Top 5 Visionary Leaders to Watch in Healthcare Industry 2023.pdf
insightscare
 
Best of 5 regenerative medicine companies 2021
Best of 5 regenerative medicine companies 2021 Best of 5 regenerative medicine companies 2021
Best of 5 regenerative medicine companies 2021
Merry D'souza
 
The 10 most eminent leaders in pharmaceutical industry, 2021 compressed
The 10 most eminent leaders in pharmaceutical industry, 2021 compressedThe 10 most eminent leaders in pharmaceutical industry, 2021 compressed
The 10 most eminent leaders in pharmaceutical industry, 2021 compressed
Insights success media and technology pvt ltd
 
10 Best Medical Aesthetic Companies to Watch.pdf
10 Best Medical Aesthetic Companies to Watch.pdf10 Best Medical Aesthetic Companies to Watch.pdf
10 Best Medical Aesthetic Companies to Watch.pdf
insightscare
 
Program Digital Health: bringing together payers & pitches. Ulli Jendrik Koop...
Program Digital Health: bringing together payers & pitches. Ulli Jendrik Koop...Program Digital Health: bringing together payers & pitches. Ulli Jendrik Koop...
Program Digital Health: bringing together payers & pitches. Ulli Jendrik Koop...
Upgraded - Health Startup Association of Finland
 
FINAL APPROVED Digital transformation of the health sector - summary record o...
FINAL APPROVED Digital transformation of the health sector - summary record o...FINAL APPROVED Digital transformation of the health sector - summary record o...
FINAL APPROVED Digital transformation of the health sector - summary record o...
SochaBlue
 
Pioneering Leaders Shaping the Future of Healthcare, 2024.pdf
Pioneering Leaders Shaping the Future of Healthcare, 2024.pdfPioneering Leaders Shaping the Future of Healthcare, 2024.pdf
Pioneering Leaders Shaping the Future of Healthcare, 2024.pdf
CIO Look Magazine
 
10 most reliable cro’s to watch in 2021
10 most reliable cro’s to watch in 202110 most reliable cro’s to watch in 2021
10 most reliable cro’s to watch in 2021
insightscare
 
Dvfa life-science-conference-proceedings-2017
Dvfa life-science-conference-proceedings-2017Dvfa life-science-conference-proceedings-2017
Dvfa life-science-conference-proceedings-2017
http://www.universidadazteca.net/study_offers
 
Outcomes in Healthcare: Fad or Future? Exploring Innovative Initiatives to Im...
Outcomes in Healthcare: Fad or Future? Exploring Innovative Initiatives to Im...Outcomes in Healthcare: Fad or Future? Exploring Innovative Initiatives to Im...
Outcomes in Healthcare: Fad or Future? Exploring Innovative Initiatives to Im...
Alix Aubert
 
AVIA 4 Aug As Released
AVIA 4 Aug As ReleasedAVIA 4 Aug As Released
AVIA 4 Aug As Released
J.B. Davis
 

Similar to Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf (20)

10 Most Innovative CRO’s To Watch In 2022.pdf
10 Most Innovative CRO’s To Watch In 2022.pdf10 Most Innovative CRO’s To Watch In 2022.pdf
10 Most Innovative CRO’s To Watch In 2022.pdf
 
The 20 most disruptive healthcare solution providers 2018
The 20 most disruptive healthcare solution providers 2018The 20 most disruptive healthcare solution providers 2018
The 20 most disruptive healthcare solution providers 2018
 
The Art of Healthcare Innovation
The Art of Healthcare InnovationThe Art of Healthcare Innovation
The Art of Healthcare Innovation
 
The 10 Successful Magnetic Leaders Revamping The Healthcare
The 10 Successful Magnetic Leaders Revamping The HealthcareThe 10 Successful Magnetic Leaders Revamping The Healthcare
The 10 Successful Magnetic Leaders Revamping The Healthcare
 
10 Most Innovative CROs To Watch In 2023.pdf
10 Most Innovative CROs To Watch In 2023.pdf10 Most Innovative CROs To Watch In 2023.pdf
10 Most Innovative CROs To Watch In 2023.pdf
 
The 10 successful magnetic leaders revamping the healthcare, 2020 compressed ...
The 10 successful magnetic leaders revamping the healthcare, 2020 compressed ...The 10 successful magnetic leaders revamping the healthcare, 2020 compressed ...
The 10 successful magnetic leaders revamping the healthcare, 2020 compressed ...
 
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
 
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
 
Top 10 pioneering leaders redefining healthcare 2021(8) compressed
Top 10 pioneering leaders redefining healthcare 2021(8) compressedTop 10 pioneering leaders redefining healthcare 2021(8) compressed
Top 10 pioneering leaders redefining healthcare 2021(8) compressed
 
Final file - Top 5 Visionary Leaders to Watch in Healthcare Industry 2023.pdf
Final file - Top 5 Visionary Leaders to Watch in Healthcare Industry 2023.pdfFinal file - Top 5 Visionary Leaders to Watch in Healthcare Industry 2023.pdf
Final file - Top 5 Visionary Leaders to Watch in Healthcare Industry 2023.pdf
 
Best of 5 regenerative medicine companies 2021
Best of 5 regenerative medicine companies 2021 Best of 5 regenerative medicine companies 2021
Best of 5 regenerative medicine companies 2021
 
The 10 most eminent leaders in pharmaceutical industry, 2021 compressed
The 10 most eminent leaders in pharmaceutical industry, 2021 compressedThe 10 most eminent leaders in pharmaceutical industry, 2021 compressed
The 10 most eminent leaders in pharmaceutical industry, 2021 compressed
 
10 Best Medical Aesthetic Companies to Watch.pdf
10 Best Medical Aesthetic Companies to Watch.pdf10 Best Medical Aesthetic Companies to Watch.pdf
10 Best Medical Aesthetic Companies to Watch.pdf
 
Program Digital Health: bringing together payers & pitches. Ulli Jendrik Koop...
Program Digital Health: bringing together payers & pitches. Ulli Jendrik Koop...Program Digital Health: bringing together payers & pitches. Ulli Jendrik Koop...
Program Digital Health: bringing together payers & pitches. Ulli Jendrik Koop...
 
FINAL APPROVED Digital transformation of the health sector - summary record o...
FINAL APPROVED Digital transformation of the health sector - summary record o...FINAL APPROVED Digital transformation of the health sector - summary record o...
FINAL APPROVED Digital transformation of the health sector - summary record o...
 
Pioneering Leaders Shaping the Future of Healthcare, 2024.pdf
Pioneering Leaders Shaping the Future of Healthcare, 2024.pdfPioneering Leaders Shaping the Future of Healthcare, 2024.pdf
Pioneering Leaders Shaping the Future of Healthcare, 2024.pdf
 
10 most reliable cro’s to watch in 2021
10 most reliable cro’s to watch in 202110 most reliable cro’s to watch in 2021
10 most reliable cro’s to watch in 2021
 
Dvfa life-science-conference-proceedings-2017
Dvfa life-science-conference-proceedings-2017Dvfa life-science-conference-proceedings-2017
Dvfa life-science-conference-proceedings-2017
 
Outcomes in Healthcare: Fad or Future? Exploring Innovative Initiatives to Im...
Outcomes in Healthcare: Fad or Future? Exploring Innovative Initiatives to Im...Outcomes in Healthcare: Fad or Future? Exploring Innovative Initiatives to Im...
Outcomes in Healthcare: Fad or Future? Exploring Innovative Initiatives to Im...
 
AVIA 4 Aug As Released
AVIA 4 Aug As ReleasedAVIA 4 Aug As Released
AVIA 4 Aug As Released
 

More from eurohealthleaders

Europe’s Most Visionary Women Leaders in Healthcare to Follow.pdf
Europe’s Most Visionary Women Leaders in Healthcare to Follow.pdfEurope’s Most Visionary Women Leaders in Healthcare to Follow.pdf
Europe’s Most Visionary Women Leaders in Healthcare to Follow.pdf
eurohealthleaders
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
eurohealthleaders
 
Way to Build a Better Healthcare Workplace – Enhancing Care.pdf
Way to Build a Better Healthcare Workplace – Enhancing Care.pdfWay to Build a Better Healthcare Workplace – Enhancing Care.pdf
Way to Build a Better Healthcare Workplace – Enhancing Care.pdf
eurohealthleaders
 
Innovative Solutions for Aging in Place and Age-Related Diseases.pptx
Innovative Solutions for Aging in Place and Age-Related Diseases.pptxInnovative Solutions for Aging in Place and Age-Related Diseases.pptx
Innovative Solutions for Aging in Place and Age-Related Diseases.pptx
eurohealthleaders
 
Women Leaders Shaping Diverse Healthcare Pathways.pptx
Women Leaders Shaping Diverse Healthcare Pathways.pptxWomen Leaders Shaping Diverse Healthcare Pathways.pptx
Women Leaders Shaping Diverse Healthcare Pathways.pptx
eurohealthleaders
 
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
eurohealthleaders
 
Women Leaders Shaping Diverse Healthcare Pathways.pdf
Women Leaders Shaping Diverse Healthcare Pathways.pdfWomen Leaders Shaping Diverse Healthcare Pathways.pdf
Women Leaders Shaping Diverse Healthcare Pathways.pdf
eurohealthleaders
 
Europe's Pioneering Leaders Shaping the Future of Healthcare- Edition 2.pdf
Europe's Pioneering Leaders Shaping the Future of Healthcare- Edition 2.pdfEurope's Pioneering Leaders Shaping the Future of Healthcare- Edition 2.pdf
Europe's Pioneering Leaders Shaping the Future of Healthcare- Edition 2.pdf
eurohealthleaders
 
Europe's Pioneering Leaders Shaping the Future of Healthcare.pdf
Europe's Pioneering Leaders Shaping the Future of Healthcare.pdfEurope's Pioneering Leaders Shaping the Future of Healthcare.pdf
Europe's Pioneering Leaders Shaping the Future of Healthcare.pdf
eurohealthleaders
 
Europe's Most Innovative Healthcare Women Leaders to Follow.pdf
Europe's Most Innovative Healthcare Women Leaders to Follow.pdfEurope's Most Innovative Healthcare Women Leaders to Follow.pdf
Europe's Most Innovative Healthcare Women Leaders to Follow.pdf
eurohealthleaders
 
Way to Build a Better Healthcare Workplace – Enhancing Care.pdf
Way to Build a Better Healthcare Workplace – Enhancing Care.pdfWay to Build a Better Healthcare Workplace – Enhancing Care.pdf
Way to Build a Better Healthcare Workplace – Enhancing Care.pdf
eurohealthleaders
 
Healthcare Leaders Uniting for Better Patient Outcomes.pdf
Healthcare Leaders Uniting for Better Patient Outcomes.pdfHealthcare Leaders Uniting for Better Patient Outcomes.pdf
Healthcare Leaders Uniting for Better Patient Outcomes.pdf
eurohealthleaders
 

More from eurohealthleaders (12)

Europe’s Most Visionary Women Leaders in Healthcare to Follow.pdf
Europe’s Most Visionary Women Leaders in Healthcare to Follow.pdfEurope’s Most Visionary Women Leaders in Healthcare to Follow.pdf
Europe’s Most Visionary Women Leaders in Healthcare to Follow.pdf
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
 
Way to Build a Better Healthcare Workplace – Enhancing Care.pdf
Way to Build a Better Healthcare Workplace – Enhancing Care.pdfWay to Build a Better Healthcare Workplace – Enhancing Care.pdf
Way to Build a Better Healthcare Workplace – Enhancing Care.pdf
 
Innovative Solutions for Aging in Place and Age-Related Diseases.pptx
Innovative Solutions for Aging in Place and Age-Related Diseases.pptxInnovative Solutions for Aging in Place and Age-Related Diseases.pptx
Innovative Solutions for Aging in Place and Age-Related Diseases.pptx
 
Women Leaders Shaping Diverse Healthcare Pathways.pptx
Women Leaders Shaping Diverse Healthcare Pathways.pptxWomen Leaders Shaping Diverse Healthcare Pathways.pptx
Women Leaders Shaping Diverse Healthcare Pathways.pptx
 
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
 
Women Leaders Shaping Diverse Healthcare Pathways.pdf
Women Leaders Shaping Diverse Healthcare Pathways.pdfWomen Leaders Shaping Diverse Healthcare Pathways.pdf
Women Leaders Shaping Diverse Healthcare Pathways.pdf
 
Europe's Pioneering Leaders Shaping the Future of Healthcare- Edition 2.pdf
Europe's Pioneering Leaders Shaping the Future of Healthcare- Edition 2.pdfEurope's Pioneering Leaders Shaping the Future of Healthcare- Edition 2.pdf
Europe's Pioneering Leaders Shaping the Future of Healthcare- Edition 2.pdf
 
Europe's Pioneering Leaders Shaping the Future of Healthcare.pdf
Europe's Pioneering Leaders Shaping the Future of Healthcare.pdfEurope's Pioneering Leaders Shaping the Future of Healthcare.pdf
Europe's Pioneering Leaders Shaping the Future of Healthcare.pdf
 
Europe's Most Innovative Healthcare Women Leaders to Follow.pdf
Europe's Most Innovative Healthcare Women Leaders to Follow.pdfEurope's Most Innovative Healthcare Women Leaders to Follow.pdf
Europe's Most Innovative Healthcare Women Leaders to Follow.pdf
 
Way to Build a Better Healthcare Workplace – Enhancing Care.pdf
Way to Build a Better Healthcare Workplace – Enhancing Care.pdfWay to Build a Better Healthcare Workplace – Enhancing Care.pdf
Way to Build a Better Healthcare Workplace – Enhancing Care.pdf
 
Healthcare Leaders Uniting for Better Patient Outcomes.pdf
Healthcare Leaders Uniting for Better Patient Outcomes.pdfHealthcare Leaders Uniting for Better Patient Outcomes.pdf
Healthcare Leaders Uniting for Better Patient Outcomes.pdf
 

Recently uploaded

Age-Related_Eye_Conditions_Presentation.pptx
Age-Related_Eye_Conditions_Presentation.pptxAge-Related_Eye_Conditions_Presentation.pptx
Age-Related_Eye_Conditions_Presentation.pptx
Damaris Akhigbe
 
Yoga for Beginner’s Course- yoga foundation course
Yoga for Beginner’s Course- yoga foundation courseYoga for Beginner’s Course- yoga foundation course
Yoga for Beginner’s Course- yoga foundation course
Karuna Yoga Vidya Peetham
 
Yoga, Anatomy & Physiology Certificate Course.pptxv.pptx
Yoga, Anatomy & Physiology Certificate Course.pptxv.pptxYoga, Anatomy & Physiology Certificate Course.pptxv.pptx
Yoga, Anatomy & Physiology Certificate Course.pptxv.pptx
Karuna Yoga Vidya Peetham
 
�� د حاتم البيطار القمةاسينمنت فاضية لطلاب القمة كورس مساعد طبيب الاسنان 2�.pdf
�� د حاتم البيطار القمةاسينمنت فاضية لطلاب القمة كورس مساعد طبيب الاسنان 2�.pdf�� د حاتم البيطار القمةاسينمنت فاضية لطلاب القمة كورس مساعد طبيب الاسنان 2�.pdf
�� د حاتم البيطار القمةاسينمنت فاضية لطلاب القمة كورس مساعد طبيب الاسنان 2�.pdf
د حاتم البيطار
 
How dental support group work...........
How dental support group work...........How dental support group work...........
How dental support group work...........
AvilasDentalGroup
 
AI in Patient Engagement and Follow-Up Care.pptx
AI in Patient Engagement and Follow-Up Care.pptxAI in Patient Engagement and Follow-Up Care.pptx
AI in Patient Engagement and Follow-Up Care.pptx
Gaurav Gupta
 
Lumbar spine physical examination in physiotherapy.pptx
Lumbar spine physical examination in physiotherapy.pptxLumbar spine physical examination in physiotherapy.pptx
Lumbar spine physical examination in physiotherapy.pptx
AvaniAkbari
 
Reimbursement Bootcamp- Coding, Coverage & Payment lecture by David Farber, K...
Reimbursement Bootcamp- Coding, Coverage & Payment lecture by David Farber, K...Reimbursement Bootcamp- Coding, Coverage & Payment lecture by David Farber, K...
Reimbursement Bootcamp- Coding, Coverage & Payment lecture by David Farber, K...
Levi Shapiro
 
HEALTH ASSESSMENT- FEMALE & MALE GENITO-URINARY SYSTEM
HEALTH ASSESSMENT- FEMALE & MALE GENITO-URINARY SYSTEMHEALTH ASSESSMENT- FEMALE & MALE GENITO-URINARY SYSTEM
HEALTH ASSESSMENT- FEMALE & MALE GENITO-URINARY SYSTEM
Rommel Luis III Israel
 
HEALTH ASSESSMENT IN NURSING - ABDOMEN (2)
HEALTH ASSESSMENT IN NURSING - ABDOMEN (2)HEALTH ASSESSMENT IN NURSING - ABDOMEN (2)
HEALTH ASSESSMENT IN NURSING - ABDOMEN (2)
Rommel Luis III Israel
 
SMET (Self-Management of Excessive Tension) Cyclic Meditation.pptxv.pptx
SMET (Self-Management of Excessive Tension)  Cyclic Meditation.pptxv.pptxSMET (Self-Management of Excessive Tension)  Cyclic Meditation.pptxv.pptx
SMET (Self-Management of Excessive Tension) Cyclic Meditation.pptxv.pptx
Karuna Yoga Vidya Peetham
 
Teaching Methodology of Hatha Yoga Teacher Training Course.pptx
Teaching Methodology of Hatha Yoga Teacher Training Course.pptxTeaching Methodology of Hatha Yoga Teacher Training Course.pptx
Teaching Methodology of Hatha Yoga Teacher Training Course.pptx
Karuna Yoga Vidya Peetham
 
buy oxycodone online at chemworldstore.net
buy oxycodone online at chemworldstore.netbuy oxycodone online at chemworldstore.net
buy oxycodone online at chemworldstore.net
luciatcupups
 
Therapeutic Diets Applied Nutrition and Dietics in BSc Nursing
Therapeutic Diets Applied Nutrition and Dietics in BSc NursingTherapeutic Diets Applied Nutrition and Dietics in BSc Nursing
Therapeutic Diets Applied Nutrition and Dietics in BSc Nursing
MKSSS BTINE
 
Extraction Vs non exraction in orthodontics.pptx
Extraction Vs  non exraction in orthodontics.pptxExtraction Vs  non exraction in orthodontics.pptx
Extraction Vs non exraction in orthodontics.pptx
Anagha Prasad
 
physiotherapy assessment & management in arthritis.pptx
physiotherapy assessment & management in arthritis.pptxphysiotherapy assessment & management in arthritis.pptx
physiotherapy assessment & management in arthritis.pptx
AvaniAkbari
 
disease condition seen in adolescent girl " ANEMIA"
disease condition seen in adolescent girl " ANEMIA"disease condition seen in adolescent girl " ANEMIA"
disease condition seen in adolescent girl " ANEMIA"
purvipatel517209
 
Legal Liability in Nursing & Healthcare Practice
Legal Liability in Nursing & Healthcare PracticeLegal Liability in Nursing & Healthcare Practice
Legal Liability in Nursing & Healthcare Practice
Esraa Mohammed Soltan
 
The Connection Between Physical and Mental Well-Being.pptx
The Connection Between Physical and Mental Well-Being.pptxThe Connection Between Physical and Mental Well-Being.pptx
The Connection Between Physical and Mental Well-Being.pptx
MartaLoveguard
 
Top Rated Massage Center In Ajman | Massage Center Deals Sharjah
Top Rated Massage Center In Ajman | Massage Center Deals SharjahTop Rated Massage Center In Ajman | Massage Center Deals Sharjah
Top Rated Massage Center In Ajman | Massage Center Deals Sharjah
Jameela Massage and Relaxation Centre Ajman
 

Recently uploaded (20)

Age-Related_Eye_Conditions_Presentation.pptx
Age-Related_Eye_Conditions_Presentation.pptxAge-Related_Eye_Conditions_Presentation.pptx
Age-Related_Eye_Conditions_Presentation.pptx
 
Yoga for Beginner’s Course- yoga foundation course
Yoga for Beginner’s Course- yoga foundation courseYoga for Beginner’s Course- yoga foundation course
Yoga for Beginner’s Course- yoga foundation course
 
Yoga, Anatomy & Physiology Certificate Course.pptxv.pptx
Yoga, Anatomy & Physiology Certificate Course.pptxv.pptxYoga, Anatomy & Physiology Certificate Course.pptxv.pptx
Yoga, Anatomy & Physiology Certificate Course.pptxv.pptx
 
�� د حاتم البيطار القمةاسينمنت فاضية لطلاب القمة كورس مساعد طبيب الاسنان 2�.pdf
�� د حاتم البيطار القمةاسينمنت فاضية لطلاب القمة كورس مساعد طبيب الاسنان 2�.pdf�� د حاتم البيطار القمةاسينمنت فاضية لطلاب القمة كورس مساعد طبيب الاسنان 2�.pdf
�� د حاتم البيطار القمةاسينمنت فاضية لطلاب القمة كورس مساعد طبيب الاسنان 2�.pdf
 
How dental support group work...........
How dental support group work...........How dental support group work...........
How dental support group work...........
 
AI in Patient Engagement and Follow-Up Care.pptx
AI in Patient Engagement and Follow-Up Care.pptxAI in Patient Engagement and Follow-Up Care.pptx
AI in Patient Engagement and Follow-Up Care.pptx
 
Lumbar spine physical examination in physiotherapy.pptx
Lumbar spine physical examination in physiotherapy.pptxLumbar spine physical examination in physiotherapy.pptx
Lumbar spine physical examination in physiotherapy.pptx
 
Reimbursement Bootcamp- Coding, Coverage & Payment lecture by David Farber, K...
Reimbursement Bootcamp- Coding, Coverage & Payment lecture by David Farber, K...Reimbursement Bootcamp- Coding, Coverage & Payment lecture by David Farber, K...
Reimbursement Bootcamp- Coding, Coverage & Payment lecture by David Farber, K...
 
HEALTH ASSESSMENT- FEMALE & MALE GENITO-URINARY SYSTEM
HEALTH ASSESSMENT- FEMALE & MALE GENITO-URINARY SYSTEMHEALTH ASSESSMENT- FEMALE & MALE GENITO-URINARY SYSTEM
HEALTH ASSESSMENT- FEMALE & MALE GENITO-URINARY SYSTEM
 
HEALTH ASSESSMENT IN NURSING - ABDOMEN (2)
HEALTH ASSESSMENT IN NURSING - ABDOMEN (2)HEALTH ASSESSMENT IN NURSING - ABDOMEN (2)
HEALTH ASSESSMENT IN NURSING - ABDOMEN (2)
 
SMET (Self-Management of Excessive Tension) Cyclic Meditation.pptxv.pptx
SMET (Self-Management of Excessive Tension)  Cyclic Meditation.pptxv.pptxSMET (Self-Management of Excessive Tension)  Cyclic Meditation.pptxv.pptx
SMET (Self-Management of Excessive Tension) Cyclic Meditation.pptxv.pptx
 
Teaching Methodology of Hatha Yoga Teacher Training Course.pptx
Teaching Methodology of Hatha Yoga Teacher Training Course.pptxTeaching Methodology of Hatha Yoga Teacher Training Course.pptx
Teaching Methodology of Hatha Yoga Teacher Training Course.pptx
 
buy oxycodone online at chemworldstore.net
buy oxycodone online at chemworldstore.netbuy oxycodone online at chemworldstore.net
buy oxycodone online at chemworldstore.net
 
Therapeutic Diets Applied Nutrition and Dietics in BSc Nursing
Therapeutic Diets Applied Nutrition and Dietics in BSc NursingTherapeutic Diets Applied Nutrition and Dietics in BSc Nursing
Therapeutic Diets Applied Nutrition and Dietics in BSc Nursing
 
Extraction Vs non exraction in orthodontics.pptx
Extraction Vs  non exraction in orthodontics.pptxExtraction Vs  non exraction in orthodontics.pptx
Extraction Vs non exraction in orthodontics.pptx
 
physiotherapy assessment & management in arthritis.pptx
physiotherapy assessment & management in arthritis.pptxphysiotherapy assessment & management in arthritis.pptx
physiotherapy assessment & management in arthritis.pptx
 
disease condition seen in adolescent girl " ANEMIA"
disease condition seen in adolescent girl " ANEMIA"disease condition seen in adolescent girl " ANEMIA"
disease condition seen in adolescent girl " ANEMIA"
 
Legal Liability in Nursing & Healthcare Practice
Legal Liability in Nursing & Healthcare PracticeLegal Liability in Nursing & Healthcare Practice
Legal Liability in Nursing & Healthcare Practice
 
The Connection Between Physical and Mental Well-Being.pptx
The Connection Between Physical and Mental Well-Being.pptxThe Connection Between Physical and Mental Well-Being.pptx
The Connection Between Physical and Mental Well-Being.pptx
 
Top Rated Massage Center In Ajman | Massage Center Deals Sharjah
Top Rated Massage Center In Ajman | Massage Center Deals SharjahTop Rated Massage Center In Ajman | Massage Center Deals Sharjah
Top Rated Massage Center In Ajman | Massage Center Deals Sharjah
 

Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf

  • 1. April Issue 04 2024 Trends, Challenges and Opportuni es The Future of Corporate Healthcare Champions of Health: Spotlight on Leaders Shaping Germany's Healthcare Dr. Cornelius Glismann Leading Tech-Driven Transforma on in Corporate Health Preven on Dr. Cornelius Glismann CEO CorporateHealth Transforma onal and Emo onal Competence Healthcare Leadership in the Digital Age
  • 5. ermany has long been admired for Gits high-quality and universal healthcare system, consistently ranking among the best in the world. It stands as a global leader in medical innovation and healthcare delivery. At the forefront of this excellence are the brilliant minds and dedicated professionals who tirelessly strive to enhance patient care and innovate novel treatments and technologies. However, the nation’s healthcare system is not stagnant – it is continuously evolving thanks to the innovative leaders working tirelessly to improve patient outcomes, drive efficiencies, and embrace the latest advancements in medical science and technology. In this exclusive issue, ‘Champions of Health: Spotlight on Leaders Shaping Germany’s Healthcare,’ we feature some of the country’s most influential healthcare visionaries across various sectors. From forward-thinking physicians and researchers to health tech entrepreneurs and policymakers, these inspiring individuals are leading profound changes that are modernizing healthcare delivery, accelerating medical breakthroughs, and improving the health and well-being of people across Germany. As the global population continues aging and the prevalence of chronic diseases rises, the need for accessible, affordable, and effective healthcare has never been greater. The champions featured in this edition are rising to meet these daunting challenges head-on through pioneering research, groundbreaking treatments, digital health solutions, and progressive policies and regulations. Their stories showcase the depth of expertise, passion for improving lives, and spirit of innovation that is driving Germany’s healthcare industry forward. We hope this window into their impactful work inspires others to join them in creating a healthier future for all. Immerse yourself into an enlightening read ahead! Sculpting a Healthier Future f or Germany -Natalie May NatalieMay
  • 6. 08 Dr. Cornelius Glismann Leading Tech-Driven Transformation in Corporate Health Prevention Cover Story
  • 7. Profiles 20 Daniel Vitt Pioneering Biotech Leadership 30 Wolfgang Ries Driving Change in Spinal Care Through Innovation and Expertise 26 36 Articles Healthcare Leadership in the Digital Age Trends, Challenges and Opportunities The Future of Corporate Healthcare Transformational and Emotional Competence
  • 8. Copyright © 2024 Insights Success Media and Technology Pvt. Ltd., All rights reserved. The content and images used in this magazine should not be reproduced or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission from Insights success. Reprint rights remain solely with Insights Success Media and Technology Pvt. Ltd. Euro Health Leaders is powered by Insights Success Media and Technology Pvt. Ltd. sales@eurohealthleaders.com Contact Us: Insights Success Media Tech LLC 555 Metro Place North, Suite 100, Dublin, OH 43017, United States Phone - +1614-602-4132 Email: info@eurohealthleaders.com For Subscription: www.eurohealthleaders.com Insights Success Media and Technology Pvt. Ltd. Survey No.133/134, Brand Square, Office No. 512, Kunjir Chowk, Pimple Saudagar, Pune, Maharashtra 411027. Phone - India: 7410033802, 8956487823 Email: info@eurohealthleaders.com For Subscription: www.eurohealthleaders.com We are also available on : Editor-in-Chief Thanh Truong Managing Editor Pearl Shaw Executive Editor Natalie May Visualiser David King Art & Design Head Samuel Martinez Co-designer Paul Belin Art & Picture Editor Grace Brown Business Development Manager Emily Jones Marketing Manager Bill Thompson Business Development Executives Anna Smith, Jack Miller Sales Executives Mike, Carl, Lisa Technical Head Jacob Smile Assistant Technical Head Joseph Taylor Technical Consultants David, Robert Digital Marketing Manager Alina Sege Assistant Digital Marketing Manager Daniel Jones SME-SMO Executive Gemson Research Analyst Eric Smith Circulation Manager James Carter L E A D E R S EUR Health APRIL, 2024 Follow us on : www.facebook.com/eurohealthleaders/ https://twitter.com/eurohealthleaders
  • 9. Brief Featuring Person Company Dr. Cornelius Glismann is a visionary leader driving the transformation of corporate healthcare through the integration of advanced technologies and personalized solutions. Daniel Vitt is committed to innovative therapies for chronic conditions and is shaping the future of healthcare. Boris Pasche is a distinguished leader with over 30 years of experience in cancer medicine and research. CorporateHealth corporatehealth-ag.com Dr. Cornelius Glismann CEO Boris Pasche Co-founder Daniel Vitt CEO & President TheraBionic therabionic.de Immunic Therapeutics imux.com Tino Galgon, an experienced professional, brings strategic vision and leadership to the forefront, driving innovation and excellence in the industry. Wolfgang Ries's expertise drives innovation in minimally invasive spinal surgery, elevating patient care to new heights. Lyocontract lyocontract.de Tino Galgon Managing Director Wolfgang Ries CEO & Founder Joimax joimax.com CHAMPIONS OF HEALTH: SPOTLIGHT ON LEADERS SHAPING GERMANY'S HEALTHCARE
  • 10. Dr. Cornelius Glismann Leading Tech-Driven Transforma on in Corporate Health Preven on I always had a high affinity for the IT sec on and got more involved in the development of the latest technology for preventa ve medical diagnos cs.
  • 12. The landscape of healthcare and preventative medicine is undergoing a profound transformation, with the integration of advanced technologies reshaping the way we approach medical care. As the worlds of health and technology converge, the need for adept leaders who can navigate this dynamic intersection becomes imperative. This exclusive feature spotlights one such figure – Dr. Cornelius Glismann, the CEO of CorporateHealth. With over two decades of experience in national and international healthcare business development, Dr. Glismann has engraved a lasting mark in the industry. His journey is marked by senior positions and influential consultations with leading global entities such as CIGNA, Fresenius/VAMED, Asklepios, Deloitte, and Beckman Coulter. Armed with an M.Sc. in Industrial Engineering from the Technical University of Aachen, Germany, and a Ph.D. in Biomedical Engineering from the University of Miami, USA, he possesses the necessary blend of technical expertise and strategic vision. In our era health prevention is increasingly becoming synonymous with personalized solutions, and Dr. Glismann's vision is right on point. His commitment to a 'segment of one' approach, even within large corporate environments like Porsche, Henkel, or Nestlé, sets CorporateHealth apart in the german industry of corporate health prevention and medical diagnostics for employees. Recently, CorporateHealth initiated the implementation of state-of-the-art AI-driven solutions that bear the potential to redefine diverse diagnostic processes. Dr. Glismann emphasized the power of these technologies, explaining how a simple scan of an individual's face can yield a comprehensive health status within a mere 30 seconds. This breakthrough not only expedites the diagnostic process in the future but also provides individuals with personalized health insights, avoiding traditional lengthy doctor visits. Our editorial team had the privilege of interacting with Dr. Glismann, unveiling the strategic decisions and innovative approaches. Venturing in Healthcare, Preventative Medicine and Technology Dr. Glismann started his career in the United States by securing a scholarship for biomedical engineering at the University of Miami. His early contributions included establishing the National Healthcare Test Center for Heart Failures, a project for the FDA that laid the foundation for his expertise in health diagnostics and the complex relationship between healthcare and technology. Following his academic pursuits, Dr. Glismann dived into the professional field with Beckman Coulter, a diagnostic company. His role in a specialized think tank focused on developing next-generation large laboratory haematology diagnostics for a global program deepened his insights into diagnostics within a specific domain. Subsequently, he returned to Europe, his home country, after spending a significant period in the United States. Reflecting on his experience in both countries, Dr. Glismann noted, "I spent a large amount in the US, which also shaped my view on healthcare because the US is much more focused on health than on patient repair." Contrasting the German healthcare system, known for its efficiency in patient care during illness, he observed a broader focus on health itself (and disease prevention) in the US. Upon his return to Europe, Dr. Glismann joined Deloitte Consulting, specializing in life sciences. In this capacity, he consulted with global and mid-sized companies, offering strategic insights into the intersection of healthcare and technology. He revealed, "My focus was mainly on health diagnostics but also using the latest technological innovations. So, throughout my whole development, I always had a high affinity for the IT section and got more involved in the development of the latest technology for preventative medical diagnostics." Quest for Innovative Prevention Medicine Dr. Glismann's journey was ignited by his experiences, particularly in the United States. Witnessing the strides made in preventive medicine and cutting-edge technology, he recognized the contrast with the state of preventative Medicine in Europe. He envisioned an efficient health promotion program based on best-practice preventative medical diagnostics that could extend beyond traditional boundaries, allowing individuals to manage their health seamlessly, even from the comfort of their homes. He emphasized, "So it's managing your health rather than just diagnosing it." The central aspect lies in empowering individuals with the knowledge and technology needed to understand and easily take actions, in an independent and convenient manner, regarding their health in daily life. Practical healthcare management, according to Dr. Glismann, centers on enabling individuals to monitor critical parameters daily. Champions of Health: Spotlight On Leaders Shaping Germany's Healthcare CorporateHealth
  • 13. Dr. Glismann's vision is anchored in the proac ve promo on of health, striving to create a paradigm shi from trea ng diseases to preserving and enhancing well-being. This proactive approach allows for early intervention or consultation, preventing the need for deeper medical interventions; with the former mitigating health-related deterioration in the affected person and the latter entailing significant savings for the healthcare systems. Establishing CorporateHealth During his tenure at Deloitte, Dr. Glismann gained invaluable insights into the strategic development and modelling of various healthcare businesses and diagnostics. Following his professional period at Deloitte, he assumed the role of director for one of Germany's largest local hospital chains. Under his leadership, the hospital underwent a transformative journey, transitioning into a private entity. This endeavour involved significant structural changes and analytical processes, providing him with a profound understanding of healthcare provisioning. His next venture led him to the Fresenius Group, where he played a pivotal role in developing and designing healthcare centres. Dr Glismann at the Sports, Medicine and Health Summit 2023 in Hamburg
  • 15. Notably, one of these centres focused on prevention, sparking Dr. Glismann's interest in scaling up preventive medicine initiatives. He recognized a gap in Germany's healthcare system, which predominantly concentrated on patient support and treatment rather than preventive measures. Driven by this insight, Dr. Glismann founded his first company—a five-star health center in Hamburg focused on preventative medicine and health promotion rather than patient repair. With a sprawling 1000 square meters of top-notch diagnostics, the center housed two leading professors from the University of Munich. Together, they developed the center from scratch, catering to private patients and corporate managers. Building on this success, Dr. Glismann joined forces with new partners and established CorporateHealth in 2012. Starting with the vision to create a prevention medicine company, CorporateHealth has since evolved into a corporate diagnostics entity. His strategic approach involved rolling out a stepwise model that has now expanded to 25 cooperating health centres across Germany. These centres are strategically contracted and integrated under an IT platform, forming a virtual chain entirely dedicated to offer health promotion programs and medical screenings for corporations, senior executives and employees. Dr. Glismann envisions CorporateHealth transforming into a comprehensive disease prevention and medical diagnostics company, transcending its initial role as a corporate diagnostics and health promotion provider for its corporate customers and patients. Pioneering Preventive Medicine and Remote Diagnostics CorporateHealth, today a frontrunner in the field of preventive medicine for corporates, Innova on in a box: The IntelliGI® pa ent box for performing colon capsule endoscopy procedures
  • 16. has ventured into the world of E-health technologies. Dr. Glismann proudly highlights the transformation of an innovative IT platform that not only manages electronic health records but also seamlessly integrates E-Health and AI-based solutions from top providers in the market. With the click of a button, individuals can now schedule appointments, access E-Health, and run AI-based solutions from the comfort of their homes. Dr. Glismann emphasizes, "We have initiated the process to soon be able to offer the full width of totally remote, hybrid, or life diagnostics, basically head to toe." This comprehensive approach allows individuals to track various health parameters, from heart health to stress levels, using smartphone technology, with the results seamlessly recorded in their electronic health records. These records can be shared with physicians for remote diagnostics or utilized for in-person life checks. CorporateHealth's commitment extends internationally, with a focus on health IT and preventive diagnostics. In 2015, Dr. Glismann, in collaboration with a partner from New York, founded CorporateHealth International. Headquartered in Denmark, the company pioneered tele- remote diagnostics, initially in regions in Denmark and later expanding to the UK and the US. He explains the revolutionary and minimally-invasive "capsule endoscopy", which enables patients to undergo comprehensive colon cancer screenings from the comfort of We have ini ated the process to soon be able to offer the full width of totally remote, hybrid or life diagnos cs, basically head to toe. their home. In this easy and reliable procedure they can scan their personal risk-level without the need for sedation or hospitalization. This technology, is especially transformative for remote areas like islands in Scotland, providing patients with challenging access to healthcare. Dr. Glismann emphasizes that this specific field focuses on early diagnostics through remote tele-diagnostics, catering to patients who benefit from remote access to healthcare. CorporateHealth Interna onal Headquarter in Inverness (Scotland), United Kingdom
  • 17. Leadership Anchored in Trust With his experience as a leader of various organizations, Dr. Glismann displays a leadership philosophy built on the bedrock of trust. According to him, trust is not just a guiding principle; it forms the very essence of his approach to running these organizations. Trust becomes the cornerstone of effective leadership in a modern work landscape where employees operate remotely, spanning different countries and continents. Dr. Glismann underscores the significance of trust, confidence, and empowerment, especially as many of his team members work from home or in diverse locations like Asia, Spain, the UK, and the US. He states, "I believe in having highly empowered employees that are passionate and whom I can trust. These employees will in return provide me with their trust because they are passionate, intrinsically motivated and engaged in their work." This reciprocal trust forms the cornerstone of a corporate culture where employees feel motivated and empowered to contribute their best. Dr. Glismann places considerable value on the conviction and dedication of his team members, relying on their passion and commitment to drive initiatives forward. This collaborative and trust-based approach not only reinforces the team's cohesion but also empowers individuals to excel in their roles. Fostering Connections Dr. Glismann actively participates in various healthcare forums, such as the Health Captain's Club, an international gathering of healthcare leaders. Additionally, he is engaged in national healthcare communities, maintaining close connections to understand the dynamics within the ecosystem at different levels. Driven by his passion for cutting-edge technologies, Dr. Glismann remains closely tied to developments in AI, E- Health, and telehealth. His involvement in these networks not only keeps him current with the latest advancements but also shapes the next steps in the development of CorporateHealth's vision. Building upon a robust platform that incorporates electronic records and appointment booking systems, CorporateHealth takes a proactive approach. They integrate the latest solutions from the market securely, ensuring the incorporation of state-of-the-art diagnostic tools. Dr. Glismann emphasizes the integration of advancements like AI-driven applications, particularly those emerging through smartphones. Sustainable Health Prevention Solutions Considering the emerging innovations and prospective changes in the health promotion landscape in Germany, Dr. Cornelius Glismann identifies several critical factors, with health-IT standing out as a prominent catalyst for change. Equally important is the element of building confidence and trust among CorporateHealth´s stakeholders, such as cooperation partners, clients and users, with a particular emphasis on GDPR compliance, a factor highly esteemed in Germany due to the country's historical context. Dr. Glismann highlights the importance of sustainability, emphasizing solutions that save resources by eliminating the need for extensive travel, doctor visits, laboratories, and blood tests. However, he notes that the effectiveness of these solutions hinges on widespread trust and adaptation by the population. The acceptance of these methods is crucial for their adoption to yield positive results. He underscores the concept of acceptance preceding adaptation, stressing that even if a product or solution is well-suited for an industry or country, it must gain acceptance, especially if trust is a factor hindering adoption.
  • 18. contribute to building trust among the people, ultimately ensuring the successful integration and acceptance of innovative solutions in preventative medicine and health diagnostics. Future-Forward Health Dr. Glismann firmly believes in the transformative impact of early detection and preventive medicine, asserting that it makes a significant difference in people's lives. His philosophy centers on keeping individuals healthy, ensuring they have the Highest Level of Care (HLC), thus optimizing the quality and value of their lifespan. The essence of this approach lies in proactively supporting health, emphasizing the importance of early detection to prevent the onset and progression of diseases. Dr. Glismann sees this as a means to enhance customers' quality of life and a pathway to a more efficient and effective healthcare system. In terms of efficiency, Dr. Glismann emphasizes the cost- effectiveness of preventive measures. Investing €1.00 in To establish and earn trust, CorporateHealth leverages strong partnerships with renowned medical centres from universities, ensuring the highest quality of medical services, whether delivered in person or through digital platforms. Industry partnerships with trusted names like IBM, Porsche, and Henkel further reinforce the reliability and safety of the technology, which is certified for GDPR compliance. Beyond technology, CorporateHealth places emphasis on personal connections and communication. Dr. Glismann notes the importance of being available around the clock, offering advice, and ensuring that a human touch is maintained. This human-centric approach, combined with innovative technology, aims to bridge the gap between cutting-edge solutions and the personal nature of health promotion services. Dr. Glismann emphasizes the role of physicians, not just IT experts, as leaders in driving technology at CorporateHealth. Collaborative partnerships, credibility, and a deep understanding of patients and the human body Together on the front line: Dr Glismann and CorporateHealth Business Director Franziska Saller
  • 19. prevention, he notes, can potentially save 10 to 100 times the cost that might be incurred in later stages of intervention and treatment. This economic efficiency aligns with the broader goal of delivering value to customers/patients while ensuring a sustainable and resource-efficient healthcare model. Dr. Glismann's vision is anchored in the proactive promotion of health, striving to create a paradigm shift from treating diseases to preserving and enhancing well-being. By focusing on early detection and preventive measures, CorporateHealth aims to not only contribute to the quality of life for individuals but also to revolutionize the efficiency and effectiveness of healthcare delivery. Dr. Glismann's Guide to Thriving in Corporate Health Promotion Dr. Glismann shares valuable advice for aspiring leaders venturing into the field of corporate health promotion and medical services in prevention medicine. He emphasizes the importance of being curious and open-minded, considering the rapid evolution occurring in this sector. However, he compares this need for curiosity with the necessity for patience, emphasizing the conservative nature of the healthcare industry in Germany and its slow yet steady cycles. Dr. Glismann underscores the long-term commitment required in this industry, distinguishing it from more fast- paced consumer-centric industries. He stresses that success in medical health promotion and all related sectors comes from understanding and embracing the enduring nature of the field. Highlighting these unique challenges of medical businesses, Dr. Glismann describes it as a complex yet fascinating system. The complexity spans from the details of the human body to the broader societal aspects, including financing and politics. According to him, the layers of complexity create a captivating environment for those who are fascinated by challenges. He points out that the slow development in the field offers a distinct advantage – the ability to learn from other sectors and adapt those learnings to their own business. This adaptability and a genuine fascination for the complexities and challenges inherent in medical services make it the right field for those who want to make a meaningful difference. In Germany, CorporateHealth has established collaborations with leading centres in preventive diagnostics, renowned for their expertise in treating athletes. These partnerships include institutions such as the University of Heidelberg, Charity in Berlin, and the University of Munich, recognized for their roles in overseeing the health of Olympic athletes. Dr. Glismann actively engages with leaders in Scotland and Denmark, contributing to the continuous enhancement of program quality. CorporateHealth is actively involved in comprehensive studies analyzing the outcomes of remote diagnostics provided. The company actively supports research trials through various partnerships, encompassing both private-public and university-public collaborations. It is not standalone but integral to a preventive healthcare community ecosystem. The interconnection of various healthcare sections, departments, and companies forms a collective effort to derive insights that contribute to individual well-being and corporate performance. Dr. Glismann acknowledges the continuous advancements in AI, health promotion and telehealth. These innovations, he believes, contribute to improving overall health outcomes and addressing issues such as mental health in the workplace.
  • 21. The role of a leader in healthcare is to create an environment where people feel empowered to provide the best possible care to patients. - Rana Awdish “
  • 22. Daniel VittPioneering Biotech Leadership Daniel Vitt CEO and President Immunic Therapeutics April 2024 www.eurohealthleaders.com 20
  • 23. Biotechnology is at the forefront of transformative healthcare advancements, and pioneering it is Daniel Vitt, Ph.D. With a background steeped in chemistry and a passion for computational modeling, Dr. Vitt co-founded 4SC AG, a pioneering biotech firm. His journey continued with the establishment of Immunic Therapeutics, where as CEO and President, he leads a mission to develop innovative therapies for chronic inflammatory and autoimmune conditions. Through creative approaches and unwavering dedication to patient welfare, Dr. Vitt is shaping the future of biotechnology, offering new avenues of treatment and hope for those in need. Let’s dive into the detailed interview to explore the transformative journey of Daniel Vitt, shaping the future of biotechnology with passion and resilience! Daniel, can you share with our readers a bit about your professional background and what inspired you to pursue a career in the biotechnology industry? Well, this started pretty unspectacular. I studied chemistry in Siegen and Würzburg in Germany where I graduated focusing on quantum-chemical calculations of organic reactions. I liked these computer simulations very much – and still do – and this drove my interest towards the potential to use computers for simulating chemistry and designing new molecules. Therefore, I received my Ph.D. from the Institute of Organic Chemistry at the University of Würzburg with my doctoral thesis focusing on the molecular design of small molecule therapeutics. Starting from my Ph.D. work, I wanted to translate some of these interesting concepts on adaptive computer modeling into a professional setup and thus, I founded 4SC AG together with three colleagues, where we developed a leading in silico screening technology – today, you would call this an AI technology. 4SC became a publicly traded biotech company and I was responsible for technology and research in the role of the Chief Scientific Officer (CSO) and Chief Development Officer (CDO). While there, we successfully transitioned the company from a technology play into an advanced therapeutic development company with several clinical-stage product candidates in the pipeline and brought the company public on Frankfurt Stock Exchange in 2005. In 2016, together with three colleagues, we took the opportunity to buy out the immunology assets from 4SC, who narrowed their development pipeline focusing on an oncology pivotal study. So, we founded Immunic in Munich. I joined Immunic in January 2017 as CEO. Searching for access to public markets, we completed a reverse takeover transaction with the US company Vital Therapies, following which we became public on NASDAQ with headquarters in New York in 2019. Since then, I have been serving as Chief Executive Officer, President and Director of Immunic. In addition to my core role at Immunic, I am currently a member of the advisory board of a venture capital fund of Bayern Kapital GmbH. On top of this, I also co-founded Brauhaus Germering GmbH, a local Bavarian specialty brewery as a kind of escalated hoppy hobby. Looking back, I think that two things inspired me most: the use of computer simulations for design purposes and the possibility to develop new therapeutics which may finally end up in a pharmacy, offering patients with severe diseases new hope. Could you elaborate on the mission and vision of Immunic Therapeutics? What sets it apart from other companies in the biotechnology sector? We founded Immunic with the mission to develop a pipeline of next generation selective oral therapies focused on offering patients with chronic inflammatory and autoimmune diseases new and clinically meaningful treatment options. We have built an advanced, diversified pipeline of clinical development candidates, ranging from preclinical to phase 3 development across different therapeutic areas and indications in immunology. OUR FOCUS IS AND HAS ALWAYS BEEN ON THE PATIENTS. AND PATIENTS DESERVE TO BENEFIT FROM SCIENTIFIC ADVANCEMENTS – WHICH ARE NATURALLY TIED TO COMMERCIAL SUCCESS. Champions of Health: Spotlight On Leaders Shaping Germany's Healthcare ,,,, ,,,, April 2024 www.eurohealthleaders.com 21
  • 24. And I think we are on the right track to achieve our mission. In particular, with our late-stage clinical program in multiple sclerosis, our vidofludimus calcium asset, we were already able to show clear separation from existing, approved MS drugs with regards to safety, tolerability and efficacy, specifically mentioning neuroprotective effects, which no other drug has shown so far. We think vidofludimus calcium has the potential to be a unique treatment option targeted to the complex biology of MS, differentiated by its combined neuroprotective, anti- inflammatory, and antiviral effects. We hope that many patients with this serious autoimmune disease and its devastating consequences for their daily life will be able to benefit from the treatment in the not too far away future. On top of this, we have a diversified earlier stage development pipeline, including our IMU-856 and IMU- 381 assets. IMU-856 is a pretty cool new approach to treating gastrointestinal disorders, aiming to regenerate the gut wall and barrier function by a new innovative targeted mechanism. We have already demonstrated clinical proof- of-concept for the molecule in celiac disease and are currently evaluating its further development path, including options in celiac disease, but also, for example, IBD or short bowel syndrome. IMU-381 is a development candidate with improved overall properties to specifically address the needs of gastrointestinal diseases. Could you discuss a key milestone or achievement during your tenure at Immunic that you are particularly proud of, and how it reflects your leadership style? I am convinced that good science and entrepreneurial spirit pave the way to success in our industry. The biggest challenge in biotech, however, is financing drug development. Looking back, it was a smart move to reverse merge with Vital Therapies in 2019 to become listed on NASDAQ – this gave us access to the capital markets and to the US investor base. Meanwhile, we were able to advance the development of our lead molecule vidofludimus calcium into clinical phase 3 in relapsing multiple sclerosis – and we also were able to demonstrate that our drug has a very unique mode of action which could change the life of millions of people suffering from MS. What are the most significant challenges and opportunities facing the biotechnology industry today, and how is Immunic positioned to address them under your leadership? I think that the financing of biotech is still by far the biggest challenge, and this needs intelligent and creative April 2024 www.eurohealthleaders.com 22
  • 25. I believe in two key success factors: passion and resilience. Without passion, it is hard to reach any goal and without resilience, you may fail even before you start the journey. Resilience also covers an important aspect in our industry: if you are convinced and you have sufficient data and a strong scientific rationale, you should focus on the goal and not let yourself be frightened too much. However, one should keep a certain level of self- reflection – personally and professionally: Am I the ghost rider – are the other 1000 coming against me? - Daniel Vitt Insights for Asping aders April 2024 23
  • 26. approaches by leaders to be solved. At Immunic, we always followed an adaptive approach and tried to build a portfolio of development programs that allows us some flexibility and independent efforts on financing, including dilutive and non-dilutive financing. The second biggest challenge from my point of view is the changing environment, including an aging population and political headwinds, such as the Inflation Reduction Act (IRA). We all need to stand together and focus on messaging to the public how important fair pricing of new treatments for unmet medical needs is, because this is the only way to finance breakthroughs in the healthcare space. How do you approach promoting innovation and driving growth within Immunic Therapeutics, ensuring a balance between scientific advancement and commercial success? Our focus is and has always been on the patients. And patients deserve to benefit from scientific advancements – which are naturally tied to commercial success. At Immunic, we start with the question “How can we improve the patient’s life?” and “What innovations can help us to be better with our approaches?” One example is our lead product vidofludimus calcium: offering patients a potential neuroprotective treatment could be a major breakthrough in the treatment landscape and change the life of many patients around the world in a sustainable way, while offering a treatment option that does not come with the typical safety and tolerability concerns of patients. Could you share a glimpse into the future of Immunic Therapeutics under your guidance, highlighting any upcoming projects or initiatives that our readers should look out for? Our key focus at the moment and the upcoming milestone we are most excited about is the readout of our phase 2 CALLIPER trial of vidofludimus calcium in progressive MS, which is expected in April 2025. If this data set continues to show a neuroprotective effect of the drug, we may be able to position vidofludimus calcium as the first oral treatment option for advanced Secondary Progressive MS (SPMS) – an indication with a particularly high unmet medical need within the MS space. In addition, we eagerly await the readout of our two phase 3 ENSURE trials of vidofludimus calcium in relapsing MS, both expected in 2026. Considering the promising clinical activity observed thus far, along with vidofludimus calcium's established safety and tolerability profile, we believe that the ENSURE program will enable a straightforward path toward potential regulatory approval. For every biotech company, this is the one key milestone to achieve, and I hope that we will see this not too far from now. April 2024 www.eurohealthleaders.com 24
  • 29. The Future of Corporate HEALTHCARE April 2024 www.eurohealthleaders.com 27 he corporate healthcare landscape is undergoing a Tsignificant transformation, driven by a confluence of factors such as technological advancements, changing workforce demographics, and evolving regulatory environments. As businesses strive to attract and retain top talent while managing rising healthcare costs, the way they approach employee health and well-being is evolving rapidly. In this article, we explore the key trends, challenges and opportunities shaping the future of corporate healthcare. Trends: 1. Embracing Digital Health Solutions: The rapid proliferation of digital health technologies, such as telemedicine, mobile health apps, and wearable devices, is revolutionizing the way healthcare is delivered within corporate settings. These technologies offer convenience, cost-effectiveness, and real-time monitoring capabilities, enabling employees to access care more readily and employers to better manage healthcare expenses. 2. Focus on Preventive Care and Wellness: Recognizing the long-term benefits and cost savings associated with preventive care, many corporations are shifting their focus toward comprehensive wellness programs. These initiatives aim to promote healthy lifestyles, improve employee engagement, and reduce the risk of chronic conditions, ultimately leading to a healthier, more productive workforce. Trends, Challenges and Opportuni es
  • 30. 3. Personalized Healthcare: With the advent of precision medicine and advanced data analytics, corporate healthcare is moving towards a more personalized approach. By leveraging employee health data, employers can tailor wellness programs, preventive screenings, and treatment plans to meet the unique needs of their workforce, leading to better health outcomes and cost optimization. 4. Workplace Mental Health Support: Mental health issues have become a growing concern in the corporate world, with stress, burnout, and anxiety taking a toll on employee well-being and productivity. As a result, companies are increasingly recognizing the importance of providing comprehensive mental health support, including employee assistance programs, counseling services, and mental health awareness initiatives. Challenges: 1. Rising Healthcare Costs: Despite efforts to control expenses, healthcare costs continue to rise, straining corporate budgets and posing a significant challenge for employers. Balancing the need to provide comprehensive healthcare coverage while managing costs remains a delicate equilibrium for many organizations. 2. Data Privacy and Security Concerns: As digital health technologies become more prevalent, concerns around data privacy and security have emerged. Employers must navigate complex regulations and implement robust data protection measures to safeguard sensitive employee health information while still leveraging the benefits of these technologies. 3. Employee Engagement and Adoption: Implementing effective corporate healthcare programs requires active employee engagement and adoption. Overcoming barriers such as lack of awareness, resistance to change, and cultural norms can be challenging, necessitating thoughtful communication strategies and incentives to encourage participation. 4. Managing a Multigenerational Workforce: With multiple generations in the workforce, corporate healthcare programs must cater to diverse needs and preferences. Tailoring programs to address the unique health concerns and communication styles of different age groups can be a complex undertaking for employers. Opportunities: 1. Leveraging Partnerships and Collaborations: Collaborating with healthcare providers, insurers, and technology companies can unlock new opportunities for corporations to enhance their healthcare offerings. By leveraging the expertise and resources of these partners, employers can gain access to cutting-edge solutions, streamline processes, and provide comprehensive care to their employees. 2. Integrating Workforce Analytics: By harnessing the power of workforce analytics, corporations can gain valuable insights into employee health trends, risk factors, and the effectiveness of their healthcare programs. These insights can inform data-driven decision-making, allowing employers to optimize their strategies and allocate resources more effectively. 3. Promoting Corporate Wellness Cultures: Creating a culture of wellness within the organization can have far- reaching benefits beyond just healthcare cost savings. A healthy workforce is often more engaged, productive, and resilient, contributing to overall organizational success. Employers have the opportunity to foster a positive work environment that prioritizes employee well-being. 4. Exploring Innovative Benefit Models: As the healthcare landscape evolves, employers can explore innovative benefit models that better align with their workforce needs and organizational goals. This could include adopting value-based healthcare models, exploring alternative care delivery methods, or implementing consumer-driven health plans. Conclusion A complex interplay of trends, challenges and opportunities shapes the future of corporate healthcare. By staying abreast of these developments and proactively addressing the challenges, corporations can position themselves to provide comprehensive, cost-effective, and innovative healthcare solutions that support the well-being of their employees and drive organizational success. -Natalie May April 2024 www.eurohealthleaders.com 28
  • 32. Wolfgang Ries CEO & Founder joimax® April 2024 www.eurohealthleaders.com 30
  • 33. ermany boasts a healthcare sector distinguished by Gits excellence, marked by world-class medical infrastructure, stringent standards, and a steadfast dedication to patient welfare. With a robust healthcare system emphasizing accessibility, quality, and innovation, Germany serves as a cornerstone in shaping the future of global healthcare. ® Wolfgang Ries, the CEO and Founder of joimax , emerges as a prominent figure within this dynamic healthcare environment. Through his entrepreneurial drive and visionary leadership, Ries has not only navigated but also significantly influenced the German healthcare ® landscape. As the driving force behind joimax , he has leveraged Germany’s healthcare expertise to propel endoscopic minimally invasive spinal surgery to unprecedented levels of success. In this edition of ‘Champions of Health: Spotlight on Leaders Shaping Germany’s Healthcare,’ we delve into Ries’ extraordinary journey, his pioneering contributions, and his steadfast commitment to advancing patient care. Let’s dive into the details below! Wolfgang, can you share with our readers a brief overview of your professional journey that led you to ® establish joimax ? As a trained telecommunication technician, I graduated from evening high school and I studied medicine later in Vienna. That was the ideal prerequisite for combining medicine and engineering to constantly drive new ideas. My motivation has always been to help people, and I have ® continuously followed this path. I started joimax in 2001 in the basement and garage of my house together with my ® wife Irmgard. Before founding joimax , I worked for 9 years in various positions in sales, product and marketing management, was VP Business Development Europe at the Baxter CardioVascular Group, now Edwards LifeScience. I was Managing Director of the Franco-German company Saphir Medical for 2 years and held during my 3 years as a consultant the position of VP Marketing & Business Development at HydroCision Inc, Andover, MA. What inspired you to focus on endoscopic minimally invasive spinal surgery within the healthcare industry? The human spine is the very sensitive but also strongest structure of the musculoskeletal system and one of its most complex organs. Wolfgang RiesDriving Change in Spinal Care Through Innovation and Expertise I believe in fostering a culture of collaboration and teamwork as well as empowerment within the organization. By encouraging open communication and valuing diverse perspectives, I ensure that decisions are well-informed and reflective of the collective wisdom of the team. Champions of Health: Spotlight on Leaders Shaping Germany's Healthcare April 2024 www.eurohealthleaders.com 31
  • 34. If there are problems within this complex system specialists are required and special technologies are needed to treat as gentle but also powerful as possible the various diseases. In 2000 I arrived in the spine field and on one hand I was shocked, how crude standard surgery was still done for small diseases then, and on the other hand how well and fast I could develop specific instruments and tools for curing with first pioneering surgeons such widespread diseases. Endoscopic minimally invasive spinal surgery has the potential to make a significant impact on patient care and healthcare delivery. By minimizing surgical trauma, reducing hospital stays, and speeding up recovery times, these techniques not only benefit individual patients but also contribute to overall healthcare efficiency and cost-effectiveness. This potential for highly meaningful clinical impact motivates me to focus efforts on advancing endoscopic spinal therapy. ® What is the core mission of joimax , and how does it guide the company’s strategic direction under your leadership? ® joimax focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. On one hand, we guarantee the best possible and particularly gentle treatment technologies for patients and, on the other hand, complete systems ensure that the surgeon can work most safely and cost-optimized on a daily basis. ® In line with the joimax philosophy “Endoscopic Spine Experts”, we develop professional medical applications using endoscopy - always adapted to the increasing needs ® of users and patients globally. joimax constantly tries to implement the latest scientific findings and technologies. In addition, the day-to-day practical experience of our customers and their ongoing feedback helps us to continuously improve our products and processes. ® How does joimax differentiate itself in the market, and what sets it apart in the field of endoscopic minimally invasive spinal surgery? ® joimax offers highly specialized complete systems for endoscopic minimally invasive spinal surgery techniques and is fully focused on this market segment. April 2024 www.eurohealthleaders.com 32
  • 35. Our strength lies in the development, manufacturing, marketing and even educating and training of all application systems, methods and devices to users around the globe. On ® the base of over 500 patents and trademarks to date joimax products are marketed in more than 60 countries, in Europe, ® America, Asia, Middle East and Africa. Under ESPINEA , ® the in 2019 inaugurated and joimax powered “Endoscopic Spine Academy,” more than 6,000 surgeons had been trained on the more than 15 systems for treating spinal diseases. Our surgical solutions enable the gentlest possible treatment, always with the patient’s well-being in mind. All systems and applications are constantly monitored and users ongoingly publish their findings and results with ® joimax systems treated patients in international well recognized journals. Outstanding product quality is guaranteed by certified quality management systems in place in accordance with international standards. In addition, products are “Made in Germany”. Above all that, ® joimax is constantly expanding the range of methods, instrument sets and the associated electronic devices. How do you approach leadership and decision-making ® within joimax , considering your extensive experience in healthcare and business? My approach is always multifaceted and adaptable to the specific needs and challenges of the organization and industry. I believe in fostering a culture of collaboration and teamwork as well as empowerment within the organization. By encouraging open communication and valuing diverse perspectives, I ensure that decisions are well-informed and reflective of the collective wisdom of the team. This approach not only enhances the quality of decision-making but also promotes employee engagement and ownership. The healthcare industry is characterized by rapid technological advancements and changes, evolving regulatory frameworks, and shifting patient demands and needs. In such a dynamic environment, I prioritize adaptability and agility in leadership and decision-making processes. This entails being receptive to change, proactively seeking opportunities for innovation, anticipating market needs and swiftly adjusting course when necessary. What key values or principles do you believe have been crucial to your success as the CEO and Founder of ® joimax ? Having a clear vision of the company’s purpose, goals, and direction provides a roadmap for success. This vision inspires and motivates both myself and my team to work towards common objectives, but also users facing the ® enthusiasm of joimax employees acting as a team driven by patient demand. Focus on our mission and prioritization on currently required tasks and duties had always been and will be key drivers for our long term and lasting success. Embracing innovation and fostering a culture of creativity and forward thinking enables us to stay ahead of the curve in a rapidly evolving industry. Placing the needs and interests of our customers at the center of everything we do ensure that our products and services are relevant, valuable, and impactful. Building strong customer relationships and actively soliciting feedback helps us continuously improve and adapt to changing market demands. Recognizing that individual success, but also global acting ® joimax teams performance, together with our customers, has to do with looking in every detail for being collectively a top performer. I value very high collaboration, teamwork, and diversity of thought within my organization. Could you highlight a significant challenge you faced in ® your career and how you overcame it to drive joimax ’s growth? ® We started to FDA register joimax products in 2005 already ® and incorporated joimax Inc. as a Delaware corporation in 2006. Until 2011 we could start developing the endoscopic spine surgery market in the USA, but as of January 2012 the reimbursement all of a sudden was blocked due to a new language in the AMA (American Medical Association) CPT Codebook. From that time onwards only cash pay and very special indications for endoscopic spinal procedures had been reimbursable. On this basis one of our start-up competitors went bankrupt and others left the US market. Together with our investors we analyzed the situation and finally decided that I will fight the US reimbursement system for obtaining a specific reimbursement schematic, which took 5 years to achieve. As of January 2017, the new AMA CPT Codebook contained the special language which from that time onwards allowed reimbursement of endoscopic spinal surgery procedures. Moreover, even a special reimbursement code was released stimulating a clear ramp-up of business activity and adoption of endoscopic spinal surgery in the USA. Today US surgeons are key drivers in highly ranked publications in top journals studying the significant cost-/outcome benefit ratios of April 2024 www.eurohealthleaders.com 33
  • 36. endoscopic spinal surgery versus traditional open surgery methods. What advice would you share with aspiring healthcare professionals and entrepreneurs looking to make a difference? Healthcare has always been but is even more ripe for innovation today, with endless opportunities to improve processes, develop new treatments, and enhance patient care. Embrace innovation and be open to exploring novel ideas and technologies that have the potential to revolutionize the industry. Stay abreast of the latest developments, trends, and challenges in healthcare. Continuously educate yourself through reading journals, attending conferences, and engaging in professional development activities to remain informed and be up to speed in your field. Always prioritize the needs and well-being of patients. Listen to their concerns, involve them in decision-making, and strive to deliver personalized, compassionate care that meets their individual preferences and values. Don’t let fear of failure hold you back from pursuing innovative ideas or opportunities. Learn from mistakes, take those to heart, rise up again and keep driving your ideas to your mission where you are assured new solutions can have its place and finally will be needed. You will be needed within a special space of activity you identify for yourself. April 2024 www.eurohealthleaders.com 34
  • 38. The healthcare industry is being reshaped by the forces of digital transformation, introducing new technologies, care delivery models, and patient expectations. Amidst this whirlwind of change, healthcare organizations are struggling with the challenge of adapting and succeeding in the digital age. Effective leadership has emerged as a critical success factor, with a growing emphasis on the complementary competencies of transformational leadership and emotional intelligence. Let us explore how these leadership styles can help attain success in the digital age! Transformational Leadership: Catalyzing Innovation and Driving Change This is a leadership approach that inspires followers to transcend their self-interests for the greater good of the organization. In the context of healthcare, transformational leaders play a crucial role in championing innovation, of cultivating a culture of continuous improvement, and effectively navigating organizational change. At the core of transformational leadership is the ability to articulate a compelling vision for the future. This vision should not only encompass technological advancements but also prioritize patient-centered care, quality improvement, and operational efficiency. By painting a clear picture of the desired future state, transformational leaders can rally their teams around a shared purpose and inspire them to embrace the changes necessary to realize that vision. Moreover, transformational leaders must create an environment that encourages creativity and innovation. Healthcare organiza- tions that cultivate a culture of psychological safety, where employees feel comfortable voicing their ideas and challenging Healthcare Leadership in the Digital Age April 2024 www.eurohealthleaders.com 36 Transforma onal and Emo onal Competence
  • 40. the status quo, are better positioned to drive innovation and stay ahead of the digital curve. Empowering teams and encouraging their participation in decision-making processes is another hallmark of transformational leadership. By delegating authority and involving team members in the change process, transformational leaders can foster a sense of ownership and commitment, ultimately increasing the likelihood of successful change implementation. Emotional Intelligence: Building Trust, Resilience, and Collaboration While transformational leadership focuses on driving change and innovation, emotional intelligence is equally crucial for healthcare leaders in the digital age. Emotional intelligence encompasses self-awareness, self-regulation, motivation, empathy, and social skills – all of which are essential for building trust, fostering resilience, and navigating the emotional complexities inherent in healthcare settings. Self-awareness, the cornerstone of emotional intelligence, allows healthcare leaders to have a deep understanding of their strengths, weaknesses, values, and emotions. This self- knowledge enables them to make informed decisions, manage their emotions effectively, and lead with authentic- ity, which is essential for building trust and credibility among their teams and stakeholders. Empathy, another key component of emotional intelligence, is particularly important in the healthcare context. Leaders who can empathize with their teams, patients, and families are better equipped to provide compassionate care and create a supportive environment that prioritizes the well- being of all stakeholders. Furthermore, emotional intelligence enables healthcare leaders to build resilience – a critical skill in the face of the ever-changing digital landscape. By effectively managing their emotions and maintaining a positive outlook, emotion- ally intelligent leaders can weather the storms of change and uncertainty, while inspiring their teams to do the same. Collaboration and effective communication are also facilitated by emotional intelligence. Leaders who possess strong social skills can build and maintain productive relationships, facilitate open dialogue, and navigate conflicts constructively – all of which are essential for driving organizational change and fostering a cohesive, high-performing team. Integrating Transformational and Emotional Compe- tence While transformational leadership and emotional intelli- gence are distinct concepts, they are inextricably linked in the context of effective healthcare leadership. Transformational leaders who possess emotional intelli- gence are better positioned to inspire and motivate their teams, build trust and credibility, and navigate the complex- ities of the digital age with grace and resilience. Emotionally intelligent transformational leaders can leverage their self-awareness and empathy to tailor their communication and change management strategies to the unique needs and concerns of their teams and stakeholders. By actively listening and addressing concerns with empathy and compassion, they can facilitate a smoother transition to new digital healthcare models and technologies, while minimizing resistance and fostering buy-in. Moreover, emotionally intelligent transformational leaders can role model the behaviors they seek to cultivate in their teams. By demonstrating self-regulation, resilience, and a growth mindset, they can inspire their teams to embrace change, learn from setbacks, and continuously develop their skills and capabilities – essential attributes for thriving in the rapidly evolving digital healthcare landscape. Conclusion In the era of digital transformation, healthcare organizations are facing unprecedented challenges and opportunities. Navigating this complex field demands a unique blend of leadership competencies that combines the visionary and change-driving qualities of transformational leadership with the interpersonal and emotional intelligence skills necessary for building trust, fostering resilience, and facilitating effective collaboration. By integrating these complementary competencies, healthcare leaders can inspire and guide their organizations through the digital age, delivering better patient outcomes and a more sustainable, future-ready healthcare system. -Natalie May April 2024 www.eurohealthleaders.com 38
  • 41. Stay in touch. Subscribe to Euro Health Leaders and get the magazine in print, & digital on www.eurohealthleaders.com Email: info@eurohealthleaders.com For Subscription: www.eurohealthleaders.com
  • 44. L E A D E R S EUR Health www.eurohealthleaders.com